US20120185040A1 - Devices, systems, and methods for retaining a native heart valve leaflet - Google Patents
Devices, systems, and methods for retaining a native heart valve leaflet Download PDFInfo
- Publication number
- US20120185040A1 US20120185040A1 US13/431,430 US201213431430A US2012185040A1 US 20120185040 A1 US20120185040 A1 US 20120185040A1 US 201213431430 A US201213431430 A US 201213431430A US 2012185040 A1 US2012185040 A1 US 2012185040A1
- Authority
- US
- United States
- Prior art keywords
- implant
- heart valve
- annulus
- scaffold
- leaflet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
Definitions
- the invention is directed to devices, systems, and methods for improving the function of a heart valve, e.g., in the treatment of mitral valve regurgitation.
- the heart (see FIG. 1B ) is slightly larger than a clenched fist. It is a double (left and right side), self-adjusting muscular pump, the parts of which work in unison to propel blood to all parts of the body.
- the right side of the heart receives poorly oxygenated (“venous”) blood from the body from the superior vena cava and inferior vena cava and pumps it through the pulmonary artery to the lungs for oxygenation.
- the left side receives well-oxygenation (“arterial”) blood from the lungs through the pulmonary veins and pumps it into the aorta for distribution to the body.
- the heart has four chambers, two on each side—the right and left atria, and the right and left ventricles.
- the atria are the blood-receiving chambers, which pump blood into the ventricles.
- the ventricles are the blood-discharging chambers.
- the synchronous pumping actions of the left and right sides of the heart constitute the cardiac cycle.
- the cycle begins with a period of ventricular relaxation, called ventricular diastole.
- the cycle ends with a period of ventricular contraction, called ventricular systole.
- the heart has four valves (see FIGS. 1B and 1C ) that ensure that blood does not flow in the wrong direction during the cardiac cycle; that is, to ensure that the blood does not back flow from the ventricles into the corresponding atria, or back flow from the arteries into the corresponding ventricles.
- the valve between the left atrium and the left ventricle is the mitral valve.
- the valve between the right atrium and the right ventricle is the tricuspid valve.
- the pulmonary valve is at the opening of the pulmonary artery.
- the aortic valve is at the opening of the aorta.
- ventricular diastole i.e., ventricular filling
- the aortic and pulmonary valves are closed to prevent back flow from the arteries into the ventricles.
- the tricuspid and mitral valves open (as FIG. 1B shows), to allow flow from the atria into the corresponding ventricles.
- the tricuspid and mitral valves close (see FIG. 1 C)—to prevent back flow from the ventricles into the corresponding atria—and the aortic and pulmonary valves open—to permit discharge of blood into the arteries from the corresponding ventricles.
- the opening and closing of heart valves occur primarily as a result of pressure differences.
- the opening and closing of the mitral valve occurs as a result of the pressure differences between the left atrium and the left ventricle.
- the mitral valve opens, allowing blood to enter the ventricle.
- the ventricle contracts during ventricular systole, the intraventricular pressure rises above the pressure in the atrium and pushes the mitral valve shut.
- FIG. 1D shows a posterior oblique cutaway view of a healthy human heart 100 .
- Two of the four heart chambers are shown, the left atrium 170 , and the left ventricle 140 (not shown are the right atrium and right ventricle).
- the left atrium 170 fills with, blood from the pulmonary veins.
- the blood then passes through the mitral valve (also known as the bicuspid valve, and more generally known as an atrioventricular valve) during ventricular diastole and into the left ventricle 140 .
- the mitral valve also known as the bicuspid valve, and more generally known as an atrioventricular valve
- the blood is then ejected out of the left ventricle 140 through the aortic valve 150 and into the aorta 160 .
- the mitral valve should be shut so that blood is not regurgitated back into the left atrium.
- the mitral valve consists of two leaflets, an anterior leaflet 110 , and a posterior leaflet 115 , attached to chordae tendineae 120 (or chords), which in turn are connected to papillary muscles 130 within the left atrium 140 .
- the mitral valve has a D-shaped anterior leaflet 110 oriented toward the aortic valve, with a crescent shaped posterior leaflet 115 .
- the leaflets intersect with the atrium 170 at the mitral annulus 190 .
- Valve malfunction can result from the chords becoming stretched, and in some cases tearing. When a chord tears, the result is a flailed leaflet. Also, a normally structured valve may not function properly because of an enlargement of the valve annulus pulling the leaflets apart. This condition is referred to as a dilation of the annulus and generally results from heart muscle failure. In addition, the valve may be defective at birth or because of an acquired disease, usually infectious or inflammatory.
- FIG. 2 shows a cutaway view of a human heart 200 with a prolapsed mitral valve.
- the prolapsed valve does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction.
- the anterior 220 and posterior 225 leaflets are shown rising higher than normal (i.e., prolapsing) into the left atrium.
- the arrows indicate the direction of regurgitant flow.
- regurgitation can result from redundant valve leaflet tissue or from stretched chords 210 that are too long to prevent the leaflets from being blown into the atrium. As a result, the leaflets do not form a tight seal, and blood is regurgitated into the atrium.
- FIG. 3 shows a cutaway view of a human heart 300 with a flailing mitral valve 320 .
- the flailing valve also does not form a tight seal during ventricular systole. Blood thus regurgitates back into the left atrium during ventricular contraction, as indicated by the arrows. Among other causes, regurgitation can also result from torn chords 310 .
- Mitral valve regurgitation can be an acute or chronic condition. It is sometimes called mitral insufficiency.
- diuretics and/or vasodilators can be used to help reduce the amount of blood flowing back into the left atrium.
- An intra-aortic balloon counterpulsation device is used if the condition is not stabilized with medications.
- surgery to repair or replace the mitral valve is often necessary.
- the invention provides devices, systems and methods that retain a native heart valve leaflet.
- the devices, systems, and methods include an implant that, in use, rests adjacent all or a portion of a valve annulus.
- the implant includes a retaining structure that is shaped to overlay at least a portion of one or more native valve leaflets.
- the implant further includes spaced-apart struts sized and configured to contact tissue near or within the heart valve annulus. The struts brace the retaining structure to resist leaflet eversion and/or prolapse. In this way, the implant prevents or reduces retrograde flow and regurgitation.
- the implant does not interfere with the opening of and blood flow through the leaflets during antegrade flow.
- FIG. 1A is a perspective, anterior anatomic view of the interior of a healthy heart.
- FIG. 1B is a superior anatomic view of the interior of a healthy heart, with the atria removed, showing the condition of the heart valves during ventricular diastole.
- FIG. 1C is a superior anatomic view of the interior of a healthy heart, with the atria removed, showing the condition of the heart valves during ventricular systole.
- FIG. 1D is a posterior oblique cutaway view of a portion of a human heart, showing a healthy mitral valve during ventricular systole, with the leaflets properly coapting.
- FIG. 2 is a posterior oblique cutaway view of a portion of a human heart, showing a dysfunctional mitral valve during ventricular systole, with the leaflets not properly coapting, causing regurgitation.
- FIG. 3 is a posterior oblique cutaway view of a portion of a human heart, showing a dysfunctional mitral valve during ventricular systole, with the leaflets flailing, causing regurgitation.
- FIG. 4 is a perspective, anatomic view of a wire form implant that includes a retaining element to resist eversion and/or prolapse of a native valve leaflet, the implant being shown installed on a mitral valve annulus.
- FIG. 5 is a side elevation view of the implant shown in FIG. 4 , shown outside of the body.
- FIG. 6 is a top view of the implant shown in FIG. 4 , shown outside the body.
- FIG. 7 is a top view of another illustrative wire form implant of the type shown in FIG. 6 .
- FIGS. 8 and 9 are top views of illustrative wire form implants of the type shown in FIGS. 4 and 5 , which include retaining elements to resist eversion and/or prolapse of a native valve leaflet, and which also include both infra-annular struts and tabs and supra-annular pads to fix the position of the implants in a valve annulus.
- FIG. 10 is a perspective view of the implant shown in FIG. 9 .
- FIG. 11 is a perspective, anatomic view of the wire form implant shown in FIG. 10 , the implant being shown installed on a mitral valve annulus.
- FIGS. 12 to 14 are perspective, anatomic views showing the intravascular introduction and deployment of the implant shown in FIG. 11 on a mitral valve annulus.
- FIG. 15 is a perspective view of an illustrative wire form implant of the type shown in FIGS. 4 and 5 , which include retaining elements to resist eversion and/or prolapse of a native valve leaflet, and which also include frameworks to orient and stabilize the position of the implants in a valve annulus.
- FIG. 16 is a top view of wire-form mesh implant that resists eversion and/or prolapse of a native valve leaflet.
- FIG. 17 is a perspective, anatomic view of the wire-form mesh implant shown in FIG. 16 installed on a mitral valve annulus.
- FIGS. 18 and 19 are top views of illustrative embodiments of implants of the types shown in FIGS. 5 and 6 , showing implants that are narrow and do not peripherally rest on the entire valve annulus.
- FIG. 20 is a top view of an illustrative embodiment of a wire-form mesh implant of the type shown in FIGS. 16 and 17 , being shown in a flattened condition for intravascular deployment, which, upon deployment, resists eversion and/or prolapse of a native valve leaflet, and which also include an auxiliary structure to orient and stabilize the position of the implants in a valve annulus, the implant in FIG. 20 also including infra-annular struts and tabs to fix the position of the implant in the valve annulus.
- FIG. 21 is a perspective, anatomic view of the wire-form mesh implant shown in FIG. 20 , installed on a mitral valve annulus.
- FIGS. 22 , 23 , and 24 are top views of illustrative embodiments of wire-form mesh implants of the type shown in FIG. 20 , which resist eversion and/or prolapse of a native valve leaflet, and which also include a combination of auxiliary structures and infra-annular struts and tabs to fix, orient, and stabilize the position of the implants in a valve annulus, the implants being shown in a flattened condition for intravascular deployment.
- FIG. 25 is a perspective view of illustrative embodiments of wire-form mesh implants of the type shown in FIG. 20 , which resist eversion and/or prolapse of a native valve leaflet, and which also include a combination of auxiliary structures and infra-annular struts and tabs to fix, orient, and stabilize the position of the implants in a valve annulus, the implants being shown in an expanded condition after intravascular deployment.
- FIGS. 4 , 5 , and 6 snow an implant 400 sized and configured to retain at least one dysfunctional native heart valve leaflet.
- the implant 400 rests adjacent all or a portion of the native heart valve annulus, which, in FIG. 4 , is in the atrium.
- the implant 400 includes a scaffold 410 , at least a portion of which defines a pseudo-annulus.
- the scaffold 410 includes a retaining element 420 at or near the pseudo-annulus.
- the retaining element 420 is sized and shaped to overlay at least a portion of the superior surface at least one native valve leaflet.
- the implant 400 allows the native leaflets to coexist with the implant 400 .
- the components of the implant 400 are made—e.g., by bending, shaping, joining, machining, molding, or extrusion—from a biocompatible metallic or polymer material, or a metallic or polymer material that is suitably coated, impregnated, or otherwise treated with a material or combination of materials to impart biocompatibility.
- the material is also desirably radio-opaque to facilitate fluoroscopic visualization.
- the implant material may be rigid, semi-rigid, or flexible.
- the scaffold 410 is sized, and configured, to rest adjacent, all or a portion of the mitral annulus in the atrium.
- the scaffold 410 forms an annular body that, at least in part, approximates the shape of the native annulus. For this reason, at least a portion of the scaffold 410 is said to define a pseudo-annulus.
- the scaffold 410 includes the retaining element 420 , which extends from the periphery of the scaffold 410 radially into the pseudo-annulus.
- the retaining element 420 is sized and configured (see FIG. 4 ) to overlay the superior surface of at least one native valve leaflet. In the illustrated embodiment, the retaining element 420 overlays regions of both leaflets. However, the retaining element 420 could be sized, configured, and oriented to overlay all or a portion of one leaflet or both leaflets. The size, configuration, and orientation of the retaining element 420 can vary, depending on patient needs, as will be described in greater detail later.
- the retaining element 420 When installed adjacent a mitral valve annulus, during ventricular systole the retaining element 420 exerts a restraining force on the superior surface of the leaflet or leaflets it overlays, resisting deflection of the leaflet or leaflets into the atrium and preventing leaflet eversion and/or prolapse as well as retrograde flow of blood through the valve during ventricular systole from the ventricle into the atrium.
- the restraining force also serves to keep valve leaflets tightly shut during peak ventricular systolic pressures.
- the retaining element 420 thus serves as a “backstop” for the leaflet or leaflets it overlays.
- the scaffold 410 and the retaining element 420 are shaped from a continuous length of wire-formed material.
- the shape and materials of the scaffold 410 and retaining element 420 provide the implant 400 with spring-like characteristics.
- the retaining element 420 is shaped so that, during ventricular systole, it elastically resists eversion and/or prolapse of the leaflet or leaflets.
- the spring-like bias of the implant 400 facilitates compliant fixation of the outer periphery of the implant 400 to or near the annulus.
- the scaffold 410 of the implant 400 dynamically conforms to the shape of the anatomy.
- the scaffold 410 can also include supra-annular contact structures 440 .
- the structures 440 are appended to the scaffold 410 to provide multiple contact regions between the implant 400 and the atrial wall, above the valve annulus. The multiple regions of contact that the structures 440 provide uniformly distributes the resting forces of the implant, and help to prevent erosion of the atrial walls and migration of the implant.
- the implant 400 can include infra-annular contact struts 430 .
- the struts 430 are appended to the scaffold 410 , extending below the plane of the annulus into the ventricular chamber.
- the struts 430 are preferably configured to extend through the valve orifice on narrow connecting members, so that they will not interfere with the opening and closing of the valve.
- the struts 430 fix and stabilize the implant within the annulus.
- the struts 430 are desirably sized and configured to contact tissue near or within the mitral valve annulus to brace the retaining structure 420 to resist leaflet eversion and/or prolapse during ventricular systole.
- the scaffold 410 be “elastic,” i.e., the material of the scaffold 410 is selected to possess a desired spring constant. This means that the scaffold 410 is sized and configured to possess a normal, unloaded, shape or condition, in which the scaffold 410 is not in net compression, and the struts 450 are spaced apart farther than the longest cross-annulus distance between the tissue that the struts 430 are intended to contact.
- the scaffold 410 shown resting along the major (i.e., longest) axis of the mitral valve annulus, with the struts 430 contact tissue at or near the leaflet commissures.
- the struts 430 need not rest at or near the leaflet commissures, but may be significantly removed from the commissures, so as to gain padding from the leaflets.
- the spring constant imparts to the scaffold 410 the ability to be elastically compressed out of its normal, unloaded condition, in response to external compression forces applied at the struts 430 .
- the scaffold 410 is sized and configured to assume an elastically loaded, in net compression condition, during which the struts 430 are spaced apart a sufficiently shorter distance to rest in engagement with tissue at or near the leaflet commissures (or wherever tissue contact with the struts 430 is intended to occur) (see FIG. 9A or 9 B).
- the scaffold 410 can exert forces to the tissues through the struts 430 . These forces hold the scaffold 410 (and thus the retaining element 420 itself) against migration within the annulus.
- the struts 430 when they are positioned at or near the commissures, they tend to outwardly displace tissue and separate tissue along the major axis of the annulus, which also typically stretches the leaflet commissures, shortens the minor axis, and/or reshapes surrounding anatomic structures.
- the scaffold 410 can also thereby reshape the valve annulus toward a shape more conducive to leaflet coaptation.
- the implant 400 may only need to reshape the annulus during a portion of the heart cycle, such as during ventricular systolic contraction.
- the implant may be sized to produce small or negligible outward displacement of tissue during ventricular diastole when the tissue is relaxed, but restrict the inward movement of tissue during ventricular systolic contraction.
- Implants having one or more of the technical features just described, to thereby function in situ as a backstop or retainer for native leaflets, may be sized and configured in various ways. Various illustrative embodiments will now be described.
- FIG. 7 shows another illustrative embodiment of an implant 400 including a scaffold 410 that defines a pseudo-annulus and a retaining element 420 that functions as a leaflet retainer 420 .
- the implant 400 is shown in a flattened condition.
- the implant 400 includes infra-annular struts 430 .
- the struts 430 contact tissue near or within the heart valve annulus, and, in particular, between or nearly between the commissures of the leaflets, and extend into the ventricular side of the valve.
- the struts 430 function to brace and secure the implant in situ.
- FIG. 8 shows yet another illustrative embodiment of an implant 400 including a scaffold 410 that defines a pseudo-annulus and a retaining element 420 that functions as a leaflet retainer.
- the implant 400 also includes infra-annular struts 430 .
- the implant 400 includes supra-annular contact structures 440 , used to disperse the loads experienced by the implant throughout the atrium.
- FIG. 9 shows other illustrative embodiment of an implant 400 including a scaffold 410 that defines a pseudo-annulus and a retaining element 420 that functions as a leaflet, retainer.
- the retaining element 420 extends across the interior of the implant in a figure eight pattern and has two support struts 430 .
- the implant 400 in FIG. 9 includes a plurality of infra-annular struts 430 and a plurality of supra-annular contact structures 440 that brace, fix, and stabilize the implants in situ.
- one or more of the struts 430 can include a superior component that, rests on the atrial side of the valve, and an inferior component that rests on the ventricular side of the valve (see FIG. 11 ).
- the struts 430 place the implant near or within a heart valve annulus, e.g., between the commissures of the leaflets.
- the shape and tension of the scaffold 410 can apply a force through the struts 430 that outwardly displaces tissue and stretches the annulus. The displacement of the tissue can remodel the annulus and promote normal valve function, free of eversion and/or prolapse, through a different mechanism than the retaining elements 420 .
- supra-annular contact structures 440 can also be used, to disperse the loads experienced by the implant throughout the atrium.
- a given implant 400 can include one or more auxiliary structures 450 to orient and stabilize the implant 400 within the left atrium.
- the implant 400 includes, in addition to the scaffold 410 and the retaining element 420 , an orientation and stabilization framework 450 .
- the framework 450 rises from the scaffold 410 above the retaining element 420 , e.g., with two substantially parallel arched wires, which connect to form a semicircular hoop above the restraining element 420 .
- the framework 450 helps to accurately position the implant 400 within the atrium, and also helps to secure the implant 400 within the atrium.
- the framework 450 does not interfere with atrial function, but instead is compliant enough to contract with the atrium.
- the implant 400 may have nonuniform flexibility to improve its function within the heart.
- the implant 400 of FIG. 15 has infra-annular struts 430 that contact tissue near or within the heart valve annulus to brace the implant 400 and assist in positioning and anchoring of the implant.
- the implant 400 may be additionally fixed to the annulus in various auxiliary ways.
- the implant 400 may be secured to the annulus with sutures or other attachment means (i.e. barbs, hooks, staples, etc.).
- sutures or other attachment means i.e. barbs, hooks, staples, etc.
- the position and orientation of the implant is desirably braced or fixed by structures appended to or carried by the implant itself, obviating reliance upon such auxiliary fixation measures.
- the retaining element 420 is sized and, configured to cover the superior surface of a single leaflet.
- FIGS. 18 and 19 show other illustrative embodiments of implants 400 sized and configured to function as leaflet retainers.
- each implant 400 includes a narrow leaflet retaining element 420 .
- the narrow leaflet retaining elements 420 span the annulus, but the associated scaffold 410 need, not peripherally follow the entire annulus.
- the implant 400 may be delivered percutaneously, thoracoscopically through the chest, or using open heart, surgical techniques. If delivered percutaneously, the implant 400 may be made from a superelastic material (for example superelastic Nitinol alloy) enabling it to be folded and collapsed such that it can be delivered in a catheter, and will subsequently self-expand into the desired shape and tension when released from the catheter. The deployment of an implant in this fashion will now be described.
- a superelastic material for example superelastic Nitinol alloy
- FIGS. 12 to 14 show a sequence of steps for a catheter-based, percutaneous deployment of an implant 400 having the technical features described.
- Percutaneous vascular access is achieved by conventional methods into the femoral or jugular vein.
- image guidance e.g., fluoroscopic, ultrasonic, magnetic resonance, computed tomography, or combinations thereof
- a first catheter (not shown) is steered through the vasculature into the right atrium.
- a needle cannula carried on the distal end of the first catheter is deployed to pierce the septum between the right and left atrium.
- a guide wire 1710 is advanced trans-septally through the needle catheter into the left atrium.
- the first catheter is withdrawn, leaving the guide wire 1710 behind.
- FIG. 12 shows the guide wire 1710 introduced through the vena cava 1730 and into the right atrium, and then through the septum 1720 between the right and left atriums, into the left atrium.
- an implant delivery catheter 1820 is advanced over the guide wire 1710 into the left atrium into proximity with the mitral valve.
- the implant delivery catheter 58 can be deployed trans-septally by means of surgical access through the right atrium.
- the implant delivery catheter 1820 carries within it a wire-form implant 400 of a type shown in FIGS. 10 and 11 , previously described.
- the implant 10 is constrained, within the catheter 1820 in a collapsed, straightened condition.
- a push rod within the catheter 1820 expels the implant (see FIG. 13 ).
- Free of the catheter 1820 the implant 400 will expand, as FIG. 14 shows.
- the implant 400 shapes and seats about the annulus, as the struts 430 seat within the commissures and the retaining elements 420 extend over the leaflets.
- the implant can also be positioned or repositioned under image guidance within the left atrium using a catheter-deployed grasping instrument.
- FIGS. 16 and 17 show another embodiment of an implant 400 including a scaffold 410 that defines a pseudo-annulus and a retaining element 420 that functions as a leaflet retainer.
- the retaining element 420 includes wire-form mesh that has been shaped to fit the heart anatomy (see FIG. 16 ).
- the wire-form mesh can be secured within the atrium with sutures or other attachment means (i.e. barbs, hooks, staples, etc.).
- the body of the wire-form mesh can be secured by spring action between the body of the implant and the walls of the heart.
- FIG. 20 another illustrative embodiment, of an implant 400 including a scaffold 410 that defines a pseudo-annulus and a retaining element 420 .
- the implant 400 is shown in a flattened out condition.
- FIG. 21 shows the implant 400 shown in FIG. 20 after deployment in a left atrium.
- the implant 400 includes a leaflet retaining element 420 , upwardly extending stabilization arch structures 440 , as well as infra-annular struts 430 , shaped and configured, as previously described.
- the arch structures 440 and struts 430 cooperate to orient, and stabilize the implant in the desired position for retaining the valve leaflets.
- FIGS. 22 , 23 , and 24 show illustrative embodiments of other implants 400 of the type shown in FIGS. 20 and 21 in flattened out conditions.
- Each of these implants 400 include a scaffold 410 that defines a pseudo-annulus and a retaining element 420 .
- the implants 400 include, in addition to a leaflet retaining element 420 , a plurality of arch structures 440 that, when deployed, contact the interior of the atrium to support and align the implant 400 , as well as infra-annular struts 430 that contact tissue near or within the heart valve annulus to brace the retaining structure 420 to resist leaflet eversion and/or prolapse during ventricular systole.
- FIG. 25 shows various illustrative embodiments of an implant 400 in a deployed conditioned.
Abstract
Description
- This application is a divisional of U.S. patent application Ser. No. 12/386,821, filed 23 Apr. 2009 (now U.S. Pat. No. 8,142,494), which is a divisional of application Ser. No. 10/676,729, filed 1 Oct. 2003 (now U.S. Pat. No. 7,527,646).
- This application is also a continuation-in-part of U.S. patent application Ser. No. 09/666,617, filed Sep. 20, 2000, now U.S. Pat. No. 6,893,459 dated May 17, 2005, and entitled “Heart Valve Annulus Device and Methods of Using Same.”
- This application is also a continuation-in-part of Patent Cooperation Treaty Application Serial No. PCT/US 02/31376, filed Oct. 1, 2002 and entitled “Systems and Devices for Heart Valve Treatments,” which claimed the benefit of U.S. Provisional Patent Application Ser. No. 60/326,590, filed Oct. 1, 2001.
- This application also claims the benefit of U.S. Provisional Application Ser. No. 60/429,444, filed Nov. 26, 2002, and entitled “Heart Valve Remodeling Devices;” U.S. Provisional Patent Application Ser. No. 60/429,709, filed Nov. 26, 2002, and entitled “Neo-Leaflet Medical Devices;” and U.S. Provisional Patent Application Ser. No. 60/429,462, filed Nov. 26, 2002, and entitled “Heart Valve Leaflet Retaining Devices,” all of the above which are each incorporated herein by reference.
- The invention is directed to devices, systems, and methods for improving the function of a heart valve, e.g., in the treatment of mitral valve regurgitation.
- The heart (see
FIG. 1B ) is slightly larger than a clenched fist. It is a double (left and right side), self-adjusting muscular pump, the parts of which work in unison to propel blood to all parts of the body. The right side of the heart receives poorly oxygenated (“venous”) blood from the body from the superior vena cava and inferior vena cava and pumps it through the pulmonary artery to the lungs for oxygenation. The left side receives well-oxygenation (“arterial”) blood from the lungs through the pulmonary veins and pumps it into the aorta for distribution to the body. - The heart has four chambers, two on each side—the right and left atria, and the right and left ventricles. The atria are the blood-receiving chambers, which pump blood into the ventricles. A wall composed, of membranous and muscular parts, called the interatrial septum, separates the right and left atria. The ventricles are the blood-discharging chambers. A wall composed of membranous and muscular parts, called the interventricular septum, separates the right and left ventricles.
- The synchronous pumping actions of the left and right sides of the heart constitute the cardiac cycle. The cycle begins with a period of ventricular relaxation, called ventricular diastole. The cycle ends with a period of ventricular contraction, called ventricular systole.
- The heart has four valves (see
FIGS. 1B and 1C ) that ensure that blood does not flow in the wrong direction during the cardiac cycle; that is, to ensure that the blood does not back flow from the ventricles into the corresponding atria, or back flow from the arteries into the corresponding ventricles. The valve between the left atrium and the left ventricle is the mitral valve. The valve between the right atrium and the right ventricle is the tricuspid valve. The pulmonary valve is at the opening of the pulmonary artery. The aortic valve is at the opening of the aorta. - At the beginning of ventricular diastole (i.e., ventricular filling) (see
FIG. 1B ), the aortic and pulmonary valves are closed to prevent back flow from the arteries into the ventricles. Shortly thereafter, the tricuspid and mitral valves open (asFIG. 1B shows), to allow flow from the atria into the corresponding ventricles. Shortly after ventricular systole (i.e., ventricular emptying) begins, the tricuspid and mitral valves close (see FIG. 1C)—to prevent back flow from the ventricles into the corresponding atria—and the aortic and pulmonary valves open—to permit discharge of blood into the arteries from the corresponding ventricles. - The opening and closing of heart valves occur primarily as a result of pressure differences. For example, the opening and closing of the mitral valve occurs as a result of the pressure differences between the left atrium and the left ventricle. During ventricular diastole, when ventricles are relaxed, the venous return of blood from the pulmonary veins into the left atrium causes the pressure in the atrium to exceed that in the ventricle. As a result, the mitral valve opens, allowing blood to enter the ventricle. As the ventricle contracts during ventricular systole, the intraventricular pressure rises above the pressure in the atrium and pushes the mitral valve shut.
-
FIG. 1D shows a posterior oblique cutaway view of a healthyhuman heart 100. Two of the four heart chambers are shown, theleft atrium 170, and the left ventricle 140 (not shown are the right atrium and right ventricle). Theleft atrium 170 fills with, blood from the pulmonary veins. The blood then passes through the mitral valve (also known as the bicuspid valve, and more generally known as an atrioventricular valve) during ventricular diastole and into theleft ventricle 140. During ventricular systole, the blood is then ejected out of theleft ventricle 140 through theaortic valve 150 and into theaorta 160. At this time, the mitral valve should be shut so that blood is not regurgitated back into the left atrium. - The mitral valve consists of two leaflets, an
anterior leaflet 110, and aposterior leaflet 115, attached to chordae tendineae 120 (or chords), which in turn are connected topapillary muscles 130 within theleft atrium 140. Typically, the mitral valve has a D-shapedanterior leaflet 110 oriented toward the aortic valve, with a crescent shapedposterior leaflet 115. The leaflets intersect with theatrium 170 at themitral annulus 190. - In a healthy heart, these muscles and their chords support the mitral and tricuspid valves, allowing the leaflets to resist the high pressure developed during contractions (pumping) of the left and right ventricles. In a healthy heart, the chords become taut, preventing the leaflets from being forced into the left or right atria and everted. Prolapse is a term used to describe the condition wherein the coaptation edges of each leaflet initially may coapt and close, but then the leaflets rise higher and the edges separate and the valve leaks. This is normally prevented by contraction of the papillary muscles and the normal length of the chords. Contraction of the papillary muscles is simultaneous with the contraction of the ventricle and serves to keep healthy valve leaflets tightly shut at peak contraction pressures exerted by the ventricle.
- Valve malfunction can result from the chords becoming stretched, and in some cases tearing. When a chord tears, the result is a flailed leaflet. Also, a normally structured valve may not function properly because of an enlargement of the valve annulus pulling the leaflets apart. This condition is referred to as a dilation of the annulus and generally results from heart muscle failure. In addition, the valve may be defective at birth or because of an acquired disease, usually infectious or inflammatory.
-
FIG. 2 shows a cutaway view of ahuman heart 200 with a prolapsed mitral valve. The prolapsed valve does not form a tight seal during ventricular systole, and thus allows blood to be regurgitated back into the left atrium during ventricular contraction. The anterior 220 and posterior 225 leaflets are shown rising higher than normal (i.e., prolapsing) into the left atrium. The arrows indicate the direction of regurgitant flow. Among other causes, regurgitation can result from redundant valve leaflet tissue or from stretchedchords 210 that are too long to prevent the leaflets from being blown into the atrium. As a result, the leaflets do not form a tight seal, and blood is regurgitated into the atrium. -
FIG. 3 shows a cutaway view of ahuman heart 300 with a flailingmitral valve 320. The flailing valve also does not form a tight seal during ventricular systole. Blood thus regurgitates back into the left atrium during ventricular contraction, as indicated by the arrows. Among other causes, regurgitation can also result from tornchords 310. - As a result of regurgitation, “extra” blood back flows into the left atrium. During subsequent ventricular diastole (when the heart relaxes), this “extra” blood returns to the left ventricle, creating a volume overload, i.e., too much blood, in the left ventricle. During subsequent ventricular systole (when the heart contracts), there is more blood in the ventricle than expected. This means that: (1) the heart must pump harder to move the extra blood; (2) too little blood may move from the heart to the rest of the body; and (3) over time, the left ventricle may begin to stretch and enlarge to accommodate the larger volume of blood, and the left ventricle may become weaker.
- Although mild cases of mitral valve regurgitation result in few problems, more severe and chronic cases eventually weaken the heart and can result in heart failure. Mitral valve regurgitation can be an acute or chronic condition. It is sometimes called mitral insufficiency.
- In the treatment of mitral valve regurgitation, diuretics and/or vasodilators can be used to help reduce the amount of blood flowing back into the left atrium. An intra-aortic balloon counterpulsation device is used if the condition is not stabilized with medications. For chronic or acute mitral valve regurgitation, surgery to repair or replace the mitral valve is often necessary.
- To date, invasive, open heart surgical approaches have been used to repair or replace the mitral valve with either a mechanical valve or biological tissue (bioprosthetic) taken from pigs, cows or horses.
- The need remains for simple, cost-effective, and less invasive devices, systems, and methods for treating dysfunction of a heart valve, e.g., in the treatment of mitral valve regurgitation.
- The invention provides devices, systems and methods that retain a native heart valve leaflet. The devices, systems, and methods include an implant that, in use, rests adjacent all or a portion of a valve annulus. The implant includes a retaining structure that is shaped to overlay at least a portion of one or more native valve leaflets. The implant further includes spaced-apart struts sized and configured to contact tissue near or within the heart valve annulus. The struts brace the retaining structure to resist leaflet eversion and/or prolapse. In this way, the implant prevents or reduces retrograde flow and regurgitation. The implant does not interfere with the opening of and blood flow through the leaflets during antegrade flow.
- Other features and advantages of the invention shall be apparent based upon the accompanying description, drawings, and claims.
-
FIG. 1A is a perspective, anterior anatomic view of the interior of a healthy heart. -
FIG. 1B is a superior anatomic view of the interior of a healthy heart, with the atria removed, showing the condition of the heart valves during ventricular diastole. -
FIG. 1C is a superior anatomic view of the interior of a healthy heart, with the atria removed, showing the condition of the heart valves during ventricular systole. -
FIG. 1D is a posterior oblique cutaway view of a portion of a human heart, showing a healthy mitral valve during ventricular systole, with the leaflets properly coapting. -
FIG. 2 is a posterior oblique cutaway view of a portion of a human heart, showing a dysfunctional mitral valve during ventricular systole, with the leaflets not properly coapting, causing regurgitation. -
FIG. 3 is a posterior oblique cutaway view of a portion of a human heart, showing a dysfunctional mitral valve during ventricular systole, with the leaflets flailing, causing regurgitation. -
FIG. 4 is a perspective, anatomic view of a wire form implant that includes a retaining element to resist eversion and/or prolapse of a native valve leaflet, the implant being shown installed on a mitral valve annulus. -
FIG. 5 is a side elevation view of the implant shown inFIG. 4 , shown outside of the body. -
FIG. 6 is a top view of the implant shown inFIG. 4 , shown outside the body. -
FIG. 7 is a top view of another illustrative wire form implant of the type shown inFIG. 6 . -
FIGS. 8 and 9 are top views of illustrative wire form implants of the type shown inFIGS. 4 and 5 , which include retaining elements to resist eversion and/or prolapse of a native valve leaflet, and which also include both infra-annular struts and tabs and supra-annular pads to fix the position of the implants in a valve annulus. -
FIG. 10 is a perspective view of the implant shown inFIG. 9 . -
FIG. 11 is a perspective, anatomic view of the wire form implant shown inFIG. 10 , the implant being shown installed on a mitral valve annulus. -
FIGS. 12 to 14 are perspective, anatomic views showing the intravascular introduction and deployment of the implant shown inFIG. 11 on a mitral valve annulus. -
FIG. 15 is a perspective view of an illustrative wire form implant of the type shown inFIGS. 4 and 5 , which include retaining elements to resist eversion and/or prolapse of a native valve leaflet, and which also include frameworks to orient and stabilize the position of the implants in a valve annulus. -
FIG. 16 is a top view of wire-form mesh implant that resists eversion and/or prolapse of a native valve leaflet. -
FIG. 17 is a perspective, anatomic view of the wire-form mesh implant shown inFIG. 16 installed on a mitral valve annulus. -
FIGS. 18 and 19 are top views of illustrative embodiments of implants of the types shown inFIGS. 5 and 6 , showing implants that are narrow and do not peripherally rest on the entire valve annulus. -
FIG. 20 is a top view of an illustrative embodiment of a wire-form mesh implant of the type shown inFIGS. 16 and 17 , being shown in a flattened condition for intravascular deployment, which, upon deployment, resists eversion and/or prolapse of a native valve leaflet, and which also include an auxiliary structure to orient and stabilize the position of the implants in a valve annulus, the implant inFIG. 20 also including infra-annular struts and tabs to fix the position of the implant in the valve annulus. -
FIG. 21 is a perspective, anatomic view of the wire-form mesh implant shown inFIG. 20 , installed on a mitral valve annulus. -
FIGS. 22 , 23, and 24 are top views of illustrative embodiments of wire-form mesh implants of the type shown inFIG. 20 , which resist eversion and/or prolapse of a native valve leaflet, and which also include a combination of auxiliary structures and infra-annular struts and tabs to fix, orient, and stabilize the position of the implants in a valve annulus, the implants being shown in a flattened condition for intravascular deployment. -
FIG. 25 is a perspective view of illustrative embodiments of wire-form mesh implants of the type shown inFIG. 20 , which resist eversion and/or prolapse of a native valve leaflet, and which also include a combination of auxiliary structures and infra-annular struts and tabs to fix, orient, and stabilize the position of the implants in a valve annulus, the implants being shown in an expanded condition after intravascular deployment. - Although the disclosure hereof is detailed, and exact to enable those skilled in the art to practice the invention, the physical embodiments herein disclosed merely exemplify the invention, which may be embodied in other specific structure. While the preferred embodiment has been described, the details may be changed without departing from the invention, which is defined by the claims.
- A. Planar Wire-Form Implants
-
FIGS. 4 , 5, and 6 snow animplant 400 sized and configured to retain at least one dysfunctional native heart valve leaflet. In use (see, in particular,FIG. 4 ), theimplant 400 rests adjacent all or a portion of the native heart valve annulus, which, inFIG. 4 , is in the atrium. Theimplant 400 includes ascaffold 410, at least a portion of which defines a pseudo-annulus. Thescaffold 410 includes a retainingelement 420 at or near the pseudo-annulus. The retainingelement 420 is sized and shaped to overlay at least a portion of the superior surface at least one native valve leaflet. Theimplant 400 allows the native leaflets to coexist with theimplant 400. - In its most basic form, the components of the
implant 400 are made—e.g., by bending, shaping, joining, machining, molding, or extrusion—from a biocompatible metallic or polymer material, or a metallic or polymer material that is suitably coated, impregnated, or otherwise treated with a material or combination of materials to impart biocompatibility. The material is also desirably radio-opaque to facilitate fluoroscopic visualization. The implant material may be rigid, semi-rigid, or flexible. - In the embodiment shown in
FIG. 4 , thescaffold 410 is sized, and configured, to rest adjacent, all or a portion of the mitral annulus in the atrium. In the illustrated embodiment (FIG. 4 ), thescaffold 410 forms an annular body that, at least in part, approximates the shape of the native annulus. For this reason, at least a portion of thescaffold 410 is said to define a pseudo-annulus. Thescaffold 410 includes the retainingelement 420, which extends from the periphery of thescaffold 410 radially into the pseudo-annulus. - The retaining
element 420 is sized and configured (seeFIG. 4 ) to overlay the superior surface of at least one native valve leaflet. In the illustrated embodiment, the retainingelement 420 overlays regions of both leaflets. However, the retainingelement 420 could be sized, configured, and oriented to overlay all or a portion of one leaflet or both leaflets. The size, configuration, and orientation of the retainingelement 420 can vary, depending on patient needs, as will be described in greater detail later. - When installed adjacent a mitral valve annulus, during ventricular systole the retaining
element 420 exerts a restraining force on the superior surface of the leaflet or leaflets it overlays, resisting deflection of the leaflet or leaflets into the atrium and preventing leaflet eversion and/or prolapse as well as retrograde flow of blood through the valve during ventricular systole from the ventricle into the atrium. The restraining force also serves to keep valve leaflets tightly shut during peak ventricular systolic pressures. The retainingelement 420 thus serves as a “backstop” for the leaflet or leaflets it overlays. During ventricular diastole this restraining force goes to zero and the retainingelement 420 does not prevent opening of the native valve leaflet or leaflets during antegrade flow. During ventricular diastole, the native valve leaflet or leaflets open normally so that blood, flow occurs from the atrium into the ventricle. Theimplant 400 thereby restores normal one-way function to the valve. - As shown in
FIGS. 5 and 6 , in the illustrated embodiment, thescaffold 410 and the retainingelement 420 are shaped from a continuous length of wire-formed material. The shape and materials of thescaffold 410 and retainingelement 420 provide theimplant 400 with spring-like characteristics. The retainingelement 420 is shaped so that, during ventricular systole, it elastically resists eversion and/or prolapse of the leaflet or leaflets. - The spring-like bias of the
implant 400 facilitates compliant fixation of the outer periphery of theimplant 400 to or near the annulus. Thescaffold 410 of theimplant 400 dynamically conforms to the shape of the anatomy. - As
FIGS. 5 and 6 show, thescaffold 410 can also include supra-annular contact structures 440. Thestructures 440 are appended to thescaffold 410 to provide multiple contact regions between theimplant 400 and the atrial wall, above the valve annulus. The multiple regions of contact that thestructures 440 provide uniformly distributes the resting forces of the implant, and help to prevent erosion of the atrial walls and migration of the implant. - Alternatively or in combination with the supra-
annular structures 440, theimplant 400 can include infra-annular contact struts 430. Thestruts 430 are appended to thescaffold 410, extending below the plane of the annulus into the ventricular chamber. Thestruts 430 are preferably configured to extend through the valve orifice on narrow connecting members, so that they will not interfere with the opening and closing of the valve. Thestruts 430 fix and stabilize the implant within the annulus. - In this arrangement, the
struts 430 are desirably sized and configured to contact tissue near or within the mitral valve annulus to brace the retainingstructure 420 to resist leaflet eversion and/or prolapse during ventricular systole. In this arrangement, it is also desirable that thescaffold 410 be “elastic,” i.e., the material of thescaffold 410 is selected to possess a desired spring constant. This means that thescaffold 410 is sized and configured to possess a normal, unloaded, shape or condition, in which thescaffold 410 is not in net compression, and thestruts 450 are spaced apart farther than the longest cross-annulus distance between the tissue that thestruts 430 are intended to contact. In the illustrated embodiment (FIG. 4 ), thescaffold 410 shown resting along the major (i.e., longest) axis of the mitral valve annulus, with thestruts 430 contact tissue at or near the leaflet commissures. However, other orientations are possible. Thestruts 430 need not rest at or near the leaflet commissures, but may be significantly removed from the commissures, so as to gain padding from the leaflets. The spring constant imparts to thescaffold 410 the ability to be elastically compressed out of its normal, unloaded condition, in response to external compression forces applied at thestruts 430. Thescaffold 410 is sized and configured to assume an elastically loaded, in net compression condition, during which thestruts 430 are spaced apart a sufficiently shorter distance to rest in engagement with tissue at or near the leaflet commissures (or wherever tissue contact with thestruts 430 is intended to occur) (seeFIG. 9A or 9B). When in its elastically loaded, net compressed condition (seeFIGS. 9A and 9B ), thescaffold 410 can exert forces to the tissues through thestruts 430. These forces hold the scaffold 410 (and thus the retainingelement 420 itself) against migration within the annulus. Furthermore, when thestruts 430 are positioned at or near the commissures, they tend to outwardly displace tissue and separate tissue along the major axis of the annulus, which also typically stretches the leaflet commissures, shortens the minor axis, and/or reshapes surrounding anatomic structures. Thescaffold 410 can also thereby reshape the valve annulus toward a shape more conducive to leaflet coaptation. It should be appreciated that, in order to be therapeutic, theimplant 400 may only need to reshape the annulus during a portion of the heart cycle, such as during ventricular systolic contraction. For example, the implant may be sized to produce small or negligible outward displacement of tissue during ventricular diastole when the tissue is relaxed, but restrict the inward movement of tissue during ventricular systolic contraction. - As just described, different forms of heart valve treatment can be provided using a
single implant 400. - Implants having one or more of the technical features just described, to thereby function in situ as a backstop or retainer for native leaflets, may be sized and configured in various ways. Various illustrative embodiments will now be described.
-
FIG. 7 shows another illustrative embodiment of animplant 400 including ascaffold 410 that defines a pseudo-annulus and a retainingelement 420 that functions as aleaflet retainer 420. InFIG. 7 , theimplant 400 is shown in a flattened condition. Theimplant 400 includes infra-annular struts 430. Upon deployment, thestruts 430 contact tissue near or within the heart valve annulus, and, in particular, between or nearly between the commissures of the leaflets, and extend into the ventricular side of the valve. As before described, thestruts 430 function to brace and secure the implant in situ. -
FIG. 8 shows yet another illustrative embodiment of animplant 400 including ascaffold 410 that defines a pseudo-annulus and a retainingelement 420 that functions as a leaflet retainer. Theimplant 400 also includes infra-annular struts 430. In addition, theimplant 400 includes supra-annular contact structures 440, used to disperse the loads experienced by the implant throughout the atrium. -
FIG. 9 shows other illustrative embodiment of animplant 400 including ascaffold 410 that defines a pseudo-annulus and a retainingelement 420 that functions as a leaflet, retainer. InFIGS. 8 and 9 , the retainingelement 420 extends across the interior of the implant in a figure eight pattern and has two support struts 430. Like the implant shown inFIG. 8 , theimplant 400 inFIG. 9 includes a plurality of infra-annular struts 430 and a plurality of supra-annular contact structures 440 that brace, fix, and stabilize the implants in situ. - As can be seen in the perspective view in
FIG. 10 , one or more of thestruts 430 can include a superior component that, rests on the atrial side of the valve, and an inferior component that rests on the ventricular side of the valve (seeFIG. 11 ). In this arrangement, thestruts 430 place the implant near or within a heart valve annulus, e.g., between the commissures of the leaflets. As before described, the shape and tension of thescaffold 410 can apply a force through thestruts 430 that outwardly displaces tissue and stretches the annulus. The displacement of the tissue can remodel the annulus and promote normal valve function, free of eversion and/or prolapse, through a different mechanism than the retainingelements 420. - Any number of supra-
annular contact structures 440 can also be used, to disperse the loads experienced by the implant throughout the atrium. - As
FIG. 15 shows, a givenimplant 400 can include one or moreauxiliary structures 450 to orient and stabilize theimplant 400 within the left atrium. InFIG. 15 , theimplant 400 includes, in addition to thescaffold 410 and the retainingelement 420, an orientation andstabilization framework 450. Theframework 450 rises from thescaffold 410 above the retainingelement 420, e.g., with two substantially parallel arched wires, which connect to form a semicircular hoop above the restrainingelement 420. Theframework 450 helps to accurately position theimplant 400 within the atrium, and also helps to secure theimplant 400 within the atrium. - Preferably the
framework 450 does not interfere with atrial function, but instead is compliant enough to contract with the atrium. As such, theimplant 400 may have nonuniform flexibility to improve its function within the heart. - Additionally, the
implant 400 ofFIG. 15 has infra-annular struts 430 that contact tissue near or within the heart valve annulus to brace theimplant 400 and assist in positioning and anchoring of the implant. - The
implant 400 may be additionally fixed to the annulus in various auxiliary ways. For example, theimplant 400 may be secured to the annulus with sutures or other attachment means (i.e. barbs, hooks, staples, etc.). Still, the position and orientation of the implant is desirably braced or fixed by structures appended to or carried by the implant itself, obviating reliance upon such auxiliary fixation measures. - In
FIG. 15 , the retainingelement 420 is sized and, configured to cover the superior surface of a single leaflet. -
FIGS. 18 and 19 show other illustrative embodiments ofimplants 400 sized and configured to function as leaflet retainers. In these embodiment, eachimplant 400 includes a narrowleaflet retaining element 420. The narrowleaflet retaining elements 420 span the annulus, but the associatedscaffold 410 need, not peripherally follow the entire annulus. - The
implant 400 may be delivered percutaneously, thoracoscopically through the chest, or using open heart, surgical techniques. If delivered percutaneously, theimplant 400 may be made from a superelastic material (for example superelastic Nitinol alloy) enabling it to be folded and collapsed such that it can be delivered in a catheter, and will subsequently self-expand into the desired shape and tension when released from the catheter. The deployment of an implant in this fashion will now be described. -
FIGS. 12 to 14 show a sequence of steps for a catheter-based, percutaneous deployment of animplant 400 having the technical features described. Percutaneous vascular access is achieved by conventional methods into the femoral or jugular vein. Under image guidance (e.g., fluoroscopic, ultrasonic, magnetic resonance, computed tomography, or combinations thereof), a first catheter (not shown) is steered through the vasculature into the right atrium. A needle cannula carried on the distal end of the first catheter is deployed to pierce the septum between the right and left atrium. Aguide wire 1710 is advanced trans-septally through the needle catheter into the left atrium. The first catheter is withdrawn, leaving theguide wire 1710 behind.FIG. 12 shows theguide wire 1710 introduced through thevena cava 1730 and into the right atrium, and then through theseptum 1720 between the right and left atriums, into the left atrium. - As
FIG. 13 shows, under image guidance, animplant delivery catheter 1820 is advanced over theguide wire 1710 into the left atrium into proximity with the mitral valve. Alternatively, the implant delivery catheter 58 can be deployed trans-septally by means of surgical access through the right atrium. - The
implant delivery catheter 1820 carries within it a wire-form implant 400 of a type shown inFIGS. 10 and 11 , previously described. The implant 10 is constrained, within thecatheter 1820 in a collapsed, straightened condition. A push rod within thecatheter 1820 expels the implant (seeFIG. 13 ). Free of thecatheter 1820, theimplant 400 will expand, asFIG. 14 shows. Progressively freed from thecatheter 1820, theimplant 400 shapes and seats about the annulus, as thestruts 430 seat within the commissures and the retainingelements 420 extend over the leaflets. The implant can also be positioned or repositioned under image guidance within the left atrium using a catheter-deployed grasping instrument. - B. Wire-Form Mesh Implants
-
FIGS. 16 and 17 show another embodiment of animplant 400 including ascaffold 410 that defines a pseudo-annulus and a retainingelement 420 that functions as a leaflet retainer. In this embodiment, the retainingelement 420 includes wire-form mesh that has been shaped to fit the heart anatomy (seeFIG. 16 ). The wire-form mesh can be secured within the atrium with sutures or other attachment means (i.e. barbs, hooks, staples, etc.). Alternatively, the body of the wire-form mesh can be secured by spring action between the body of the implant and the walls of the heart. - In
FIG. 20 , another illustrative embodiment, of animplant 400 including ascaffold 410 that defines a pseudo-annulus and a retainingelement 420. Theimplant 400 is shown in a flattened out condition.FIG. 21 shows theimplant 400 shown inFIG. 20 after deployment in a left atrium. Theimplant 400 includes aleaflet retaining element 420, upwardly extending stabilizationarch structures 440, as well as infra-annular struts 430, shaped and configured, as previously described. Thearch structures 440 and struts 430 cooperate to orient, and stabilize the implant in the desired position for retaining the valve leaflets. -
FIGS. 22 , 23, and 24 show illustrative embodiments ofother implants 400 of the type shown inFIGS. 20 and 21 in flattened out conditions. Each of theseimplants 400 include ascaffold 410 that defines a pseudo-annulus and a retainingelement 420. In these embodiments, theimplants 400 include, in addition to aleaflet retaining element 420, a plurality ofarch structures 440 that, when deployed, contact the interior of the atrium to support and align theimplant 400, as well as infra-annular struts 430 that contact tissue near or within the heart valve annulus to brace the retainingstructure 420 to resist leaflet eversion and/or prolapse during ventricular systole.FIG. 25 shows various illustrative embodiments of animplant 400 in a deployed conditioned. - While the new devices and methods have been more specifically described in the context of the treatment of a mitral heart valve, it should be understood that other heart valve types can be treated in the same or equivalent fashion. By way of example, and not by limitation, the present systems and methods could be used, to resist or prevent retrograde flow in any heart valve annulus, including the tricuspid valve, the pulmonary valve, or the aortic valve. In addition, other embodiments and uses of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. The specification and examples should be considered exemplary and merely descriptive of key technical features and principles, and are not meant to be limiting. The true scope and spirit of the invention are defined by the following claims. As will be easily understood by those of ordinary skill in the art, variations and modifications of each of the disclosed embodiments can be easily made within the scope of this invention as defined by the following claims.
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/431,430 US20120185040A1 (en) | 2000-09-20 | 2012-03-27 | Devices, systems, and methods for retaining a native heart valve leaflet |
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/666,617 US6893459B1 (en) | 2000-09-20 | 2000-09-20 | Heart valve annulus device and method of using same |
US32659001P | 2001-10-01 | 2001-10-01 | |
PCT/US2002/031376 WO2003028558A2 (en) | 2001-10-01 | 2002-10-01 | Methods and devices for heart valve treatments |
US42944402P | 2002-11-26 | 2002-11-26 | |
US42970902P | 2002-11-26 | 2002-11-26 | |
US42946202P | 2002-11-26 | 2002-11-26 | |
US10/676,729 US7527646B2 (en) | 2000-09-20 | 2003-10-01 | Devices, systems, and methods for retaining a native heart valve leaflet |
US12/386,821 US8142494B2 (en) | 2000-09-20 | 2009-04-23 | Devices, systems, and methods for retaining a native heart valve leaflet |
US13/431,430 US20120185040A1 (en) | 2000-09-20 | 2012-03-27 | Devices, systems, and methods for retaining a native heart valve leaflet |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/386,821 Division US8142494B2 (en) | 2000-09-20 | 2009-04-23 | Devices, systems, and methods for retaining a native heart valve leaflet |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120185040A1 true US20120185040A1 (en) | 2012-07-19 |
Family
ID=45353279
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/676,815 Expired - Lifetime US7381220B2 (en) | 2000-09-20 | 2003-10-01 | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet |
US11/981,025 Expired - Fee Related US8016882B2 (en) | 2000-09-20 | 2007-10-31 | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet |
US13/227,630 Expired - Lifetime US9610161B2 (en) | 2000-09-20 | 2011-09-08 | Devices, systems, and methods for supplementing, repairing or replacing a native heart valve leaflet |
US13/431,430 Abandoned US20120185040A1 (en) | 2000-09-20 | 2012-03-27 | Devices, systems, and methods for retaining a native heart valve leaflet |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/676,815 Expired - Lifetime US7381220B2 (en) | 2000-09-20 | 2003-10-01 | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet |
US11/981,025 Expired - Fee Related US8016882B2 (en) | 2000-09-20 | 2007-10-31 | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet |
US13/227,630 Expired - Lifetime US9610161B2 (en) | 2000-09-20 | 2011-09-08 | Devices, systems, and methods for supplementing, repairing or replacing a native heart valve leaflet |
Country Status (3)
Country | Link |
---|---|
US (4) | US7381220B2 (en) |
AU (1) | AU2003277115A1 (en) |
WO (1) | WO2004030568A2 (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110202129A1 (en) * | 2008-10-10 | 2011-08-18 | Milux Holding S.A. | Improved artificial valve |
US20120179247A1 (en) * | 2007-11-19 | 2012-07-12 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US9224542B2 (en) | 2012-07-26 | 2015-12-29 | Samsung Electronics Co., Ltd. | Conductive layered structure, electrode and supercapacitor comprising the conductive layered structure, and method for preparing the conductive layered structure |
US9610161B2 (en) * | 2000-09-20 | 2017-04-04 | Mvrx, Inc. | Devices, systems, and methods for supplementing, repairing or replacing a native heart valve leaflet |
US10022223B2 (en) | 2015-10-06 | 2018-07-17 | W. L. Gore & Associates, Inc. | Leaflet support devices and methods of making and using the same |
US10349982B2 (en) | 2011-11-01 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US10478232B2 (en) | 2009-04-29 | 2019-11-19 | Nuvasive Specialized Orthopedics, Inc. | Interspinous process device and method |
US10617453B2 (en) | 2015-10-16 | 2020-04-14 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US10646262B2 (en) | 2011-02-14 | 2020-05-12 | Nuvasive Specialized Orthopedics, Inc. | System and method for altering rotational alignment of bone sections |
US10660675B2 (en) | 2010-06-30 | 2020-05-26 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10729470B2 (en) | 2008-11-10 | 2020-08-04 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10743794B2 (en) | 2011-10-04 | 2020-08-18 | Nuvasive Specialized Orthopedics, Inc. | Devices and methods for non-invasive implant length sensing |
US10751094B2 (en) | 2013-10-10 | 2020-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable spinal implant |
US10835290B2 (en) | 2015-12-10 | 2020-11-17 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10918425B2 (en) | 2016-01-28 | 2021-02-16 | Nuvasive Specialized Orthopedics, Inc. | System and methods for bone transport |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11191579B2 (en) | 2012-10-29 | 2021-12-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US11202707B2 (en) | 2008-03-25 | 2021-12-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant system |
US11234849B2 (en) | 2006-10-20 | 2022-02-01 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US11246694B2 (en) | 2014-04-28 | 2022-02-15 | Nuvasive Specialized Orthopedics, Inc. | System for informational magnetic feedback in adjustable implants |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11357549B2 (en) | 2004-07-02 | 2022-06-14 | Nuvasive Specialized Orthopedics, Inc. | Expandable rod system to treat scoliosis and method of using the same |
US11439449B2 (en) | 2014-12-26 | 2022-09-13 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US11612416B2 (en) | 2015-02-19 | 2023-03-28 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US11951008B2 (en) | 2020-09-30 | 2024-04-09 | Edwards Lifesciences Corporation | Leaflet support devices and methods of making and using the same |
Families Citing this family (433)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006134A (en) * | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US10327743B2 (en) * | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US8016877B2 (en) * | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US20070043435A1 (en) * | 1999-11-17 | 2007-02-22 | Jacques Seguin | Non-cylindrical prosthetic valve system for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US6458153B1 (en) * | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
AU2001273088A1 (en) * | 2000-06-30 | 2002-01-30 | Viacor Incorporated | Intravascular filter with debris entrapment mechanism |
EP1401358B1 (en) * | 2000-06-30 | 2016-08-17 | Medtronic, Inc. | Apparatus for performing a procedure on a cardiac valve |
CN1447669A (en) | 2000-08-18 | 2003-10-08 | 阿特里泰克公司 | Expandable implant devices for filtering blood flow from atrial appendages |
WO2004030570A2 (en) * | 2002-10-01 | 2004-04-15 | Ample Medical, Inc. | Devices for retaining native heart valve leaflet |
WO2004030569A2 (en) * | 2002-10-01 | 2004-04-15 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US7544206B2 (en) * | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8771302B2 (en) * | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
FR2826863B1 (en) * | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7097659B2 (en) * | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US20080249504A1 (en) * | 2007-04-06 | 2008-10-09 | Lattouf Omar M | Instrument port |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7007698B2 (en) * | 2002-04-03 | 2006-03-07 | Boston Scientific Corporation | Body lumen closure |
US6752828B2 (en) * | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
US8721713B2 (en) * | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
CO5500017A1 (en) * | 2002-09-23 | 2005-03-31 | 3F Therapeutics Inc | MITRAL PROTESTIC VALVE |
US7087064B1 (en) | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
CA2502967A1 (en) * | 2002-10-24 | 2004-05-06 | Boston Scientific Limited | Venous valve apparatus and method |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7981152B1 (en) | 2004-12-10 | 2011-07-19 | Advanced Cardiovascular Systems, Inc. | Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sites |
US9149602B2 (en) | 2005-04-22 | 2015-10-06 | Advanced Cardiovascular Systems, Inc. | Dual needle delivery system |
US7485143B2 (en) | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
US7335213B1 (en) | 2002-11-15 | 2008-02-26 | Abbott Cardiovascular Systems Inc. | Apparatus and methods for heart valve repair |
US7404824B1 (en) | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US8187324B2 (en) | 2002-11-15 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Telescoping apparatus for delivering and adjusting a medical device in a vessel |
US6945957B2 (en) * | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US6997950B2 (en) * | 2003-01-16 | 2006-02-14 | Chawla Surendra K | Valve repair device |
US7393339B2 (en) * | 2003-02-21 | 2008-07-01 | C. R. Bard, Inc. | Multi-lumen catheter with separate distal tips |
US7380163B2 (en) * | 2003-04-23 | 2008-05-27 | Dot Hill Systems Corporation | Apparatus and method for deterministically performing active-active failover of redundant servers in response to a heartbeat link failure |
CA2533353A1 (en) | 2003-07-21 | 2005-02-03 | The Trustees Of The University Of Pennsylvania | Percutaneous heart valve |
US7998112B2 (en) | 2003-09-30 | 2011-08-16 | Abbott Cardiovascular Systems Inc. | Deflectable catheter assembly and method of making same |
US9579194B2 (en) * | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7854761B2 (en) * | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US9005273B2 (en) * | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
EP2529699B1 (en) | 2003-12-23 | 2014-01-29 | Sadra Medical, Inc. | Repositionable heart valve |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8951299B2 (en) | 2003-12-23 | 2015-02-10 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US8182528B2 (en) * | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
US8979922B2 (en) | 2004-03-11 | 2015-03-17 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
EP1753374A4 (en) | 2004-04-23 | 2010-02-10 | 3F Therapeutics Inc | Implantable prosthetic valve |
US7276078B2 (en) * | 2004-06-30 | 2007-10-02 | Edwards Lifesciences Pvt | Paravalvular leak detection, sealing, and prevention |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US20060052867A1 (en) * | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
CA2580053C (en) | 2004-09-14 | 2014-07-08 | Edwards Lifesciences Ag. | Device and method for treatment of heart valve regurgitation |
US20090043381A1 (en) * | 2004-10-05 | 2009-02-12 | Macoviak John A | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
WO2006054107A2 (en) * | 2004-11-19 | 2006-05-26 | Medtronic Inc. | Method and apparatus for treatment of cardiac valves |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US7854755B2 (en) * | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US20060173490A1 (en) * | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
EP3967269A3 (en) | 2005-02-07 | 2022-07-13 | Evalve, Inc. | Systems and devices for cardiac valve repair |
US7670368B2 (en) * | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
US7867274B2 (en) * | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
WO2006097931A2 (en) | 2005-03-17 | 2006-09-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US7722666B2 (en) * | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
WO2006113906A1 (en) * | 2005-04-20 | 2006-10-26 | The Cleveland Clinic Foundation | Apparatus and method for replacing a cardiac valve |
SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US7780723B2 (en) * | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
MX2008002552A (en) | 2005-09-07 | 2008-04-21 | Medtentia Ab | A device and method for improving the function of a heart valve. |
US7569071B2 (en) * | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US20070078510A1 (en) | 2005-09-26 | 2007-04-05 | Ryan Timothy R | Prosthetic cardiac and venous valves |
US8167932B2 (en) | 2005-10-18 | 2012-05-01 | Edwards Lifesciences Corporation | Heart valve delivery system with valve catheter |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US9078781B2 (en) * | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
US7799038B2 (en) * | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
EP1988851A2 (en) | 2006-02-14 | 2008-11-12 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
EP2583640B1 (en) * | 2006-02-16 | 2022-06-22 | Venus MedTech (HangZhou), Inc. | Minimally invasive replacement heart valve |
US7749249B2 (en) | 2006-02-21 | 2010-07-06 | Kardium Inc. | Method and device for closing holes in tissue |
US7648527B2 (en) * | 2006-03-01 | 2010-01-19 | Cook Incorporated | Methods of reducing retrograde flow |
US8075615B2 (en) | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
EP2032080B1 (en) | 2006-06-01 | 2017-05-03 | Edwards Lifesciences Corporation | Prosthetic insert for improving heart valve function |
US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
US20080033541A1 (en) * | 2006-08-02 | 2008-02-07 | Daniel Gelbart | Artificial mitral valve |
US7837610B2 (en) | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
WO2008031103A2 (en) | 2006-09-08 | 2008-03-13 | Edwards Lifesciences Corporation | Integrated heart valve delivery system |
US8348996B2 (en) | 2006-09-19 | 2013-01-08 | Medtronic Ventor Technologies Ltd. | Valve prosthesis implantation techniques |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
WO2008047354A2 (en) | 2006-10-16 | 2008-04-24 | Ventor Technologies Ltd. | Transapical delivery system with ventriculo-arterial overflow bypass |
SE530568C2 (en) * | 2006-11-13 | 2008-07-08 | Medtentia Ab | Medical device for improving function of heart valve, has flange unit connected to loop-shaped support and provided to be arranged against annulus when loop shaped support abut heart valve |
US9974653B2 (en) | 2006-12-05 | 2018-05-22 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
JP2010511469A (en) | 2006-12-05 | 2010-04-15 | バルテック カーディオ,リミティド | Segmented ring placement |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
US8747459B2 (en) * | 2006-12-06 | 2014-06-10 | Medtronic Corevalve Llc | System and method for transapical delivery of an annulus anchored self-expanding valve |
WO2008091493A1 (en) | 2007-01-08 | 2008-07-31 | California Institute Of Technology | In-situ formation of a valve |
US7678144B2 (en) * | 2007-01-29 | 2010-03-16 | Cook Incorporated | Prosthetic valve with slanted leaflet design |
WO2008097589A1 (en) | 2007-02-05 | 2008-08-14 | Boston Scientific Limited | Percutaneous valve, system, and method |
JP5604110B2 (en) * | 2007-02-05 | 2014-10-08 | ボストン サイエンティフィック リミテッド | System for delivering a valve |
CA2677633C (en) * | 2007-02-15 | 2015-09-08 | Medtronic, Inc. | Multi-layered stents and methods of implanting |
EP2129333B1 (en) * | 2007-02-16 | 2019-04-03 | Medtronic, Inc | Replacement prosthetic heart valves |
US20080208328A1 (en) * | 2007-02-23 | 2008-08-28 | Endovalve, Inc. | Systems and Methods For Placement of Valve Prosthesis System |
US8070802B2 (en) * | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
US8529620B2 (en) * | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
US8828079B2 (en) * | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US20090138079A1 (en) * | 2007-10-10 | 2009-05-28 | Vector Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8216303B2 (en) * | 2007-11-19 | 2012-07-10 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US7892276B2 (en) * | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US20090171456A1 (en) * | 2007-12-28 | 2009-07-02 | Kveen Graig L | Percutaneous heart valve, system, and method |
US8100962B2 (en) * | 2008-01-08 | 2012-01-24 | Cook Medical Technologies Llc | Flow-deflecting prosthesis for treating venous disease |
US8157853B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9149358B2 (en) * | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
JP5687070B2 (en) * | 2008-01-24 | 2015-03-18 | メドトロニック,インコーポレイテッド | Stent for prosthetic heart valve |
EP2254513B1 (en) * | 2008-01-24 | 2015-10-28 | Medtronic, Inc. | Stents for prosthetic heart valves |
EP2254512B1 (en) | 2008-01-24 | 2016-01-06 | Medtronic, Inc. | Markers for prosthetic heart valves |
US20090287290A1 (en) * | 2008-01-24 | 2009-11-19 | Medtronic, Inc. | Delivery Systems and Methods of Implantation for Prosthetic Heart Valves |
EP2244668A1 (en) | 2008-01-25 | 2010-11-03 | JenaValve Technology Inc. | Medical apparatus for the therapeutic treatment of an insufficient cardiac valve |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
BR112012021347A2 (en) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
EP3005984A1 (en) | 2008-02-28 | 2016-04-13 | Medtronic Inc. | Prosthetic heart valve systems |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US20100121435A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Percutaneous transvalvular intrannular band for mitral valve repair |
US11013599B2 (en) | 2008-04-16 | 2021-05-25 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US20100131057A1 (en) | 2008-04-16 | 2010-05-27 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for aortic valve repair |
US11083579B2 (en) | 2008-04-16 | 2021-08-10 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US10456259B2 (en) | 2008-04-16 | 2019-10-29 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for mitral valve repair |
US8262725B2 (en) * | 2008-04-16 | 2012-09-11 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for valve repair |
US20100121437A1 (en) | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
US8696743B2 (en) * | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US20090287304A1 (en) | 2008-05-13 | 2009-11-19 | Kardium Inc. | Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve |
ATE554731T1 (en) | 2008-05-16 | 2012-05-15 | Sorin Biomedica Cardio Srl | ATRAAUMATIC PROSTHETIC HEART VALVE PROSTHESIS |
EP2296744B1 (en) | 2008-06-16 | 2019-07-31 | Valtech Cardio, Ltd. | Annuloplasty devices |
EP4018967A1 (en) | 2008-09-15 | 2022-06-29 | Medtronic Ventor Technologies Ltd | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US8137398B2 (en) * | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
EP4321134A2 (en) | 2008-11-21 | 2024-02-14 | Percutaneous Cardiovascular Solutions Pty Limited | Heart valve prosthesis and method |
US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
CN102341063B (en) | 2008-12-22 | 2015-11-25 | 瓦尔泰克卡迪欧有限公司 | Adjustable annuloplasty device and governor motion thereof |
US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
EP2381895B1 (en) * | 2008-12-31 | 2021-07-07 | Medtronic, Inc. | Semi-rigid annuloplasty ring and band and method of making an annuloplasty ring |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
CA2759242A1 (en) * | 2009-03-17 | 2010-09-23 | Mitrassist Medical Ltd. | Heart valve prosthesis with collapsible valve and method of delivery thereof |
US9011522B2 (en) | 2009-04-10 | 2015-04-21 | Lon Sutherland ANNEST | Device and method for temporary or permanent suspension of an implantable scaffolding containing an orifice for placement of a prosthetic or bio-prosthetic valve |
ES2523218T3 (en) | 2009-04-27 | 2014-11-24 | Sorin Group Italia S.R.L. | Prosthetic vascular duct |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
EP2448529A1 (en) | 2009-06-29 | 2012-05-09 | Cook Medical Technologies LLC | Slotted pusher rod for flexible delivery system |
US20110077733A1 (en) * | 2009-09-25 | 2011-03-31 | Edwards Lifesciences Corporation | Leaflet contacting apparatus and method |
US20110082538A1 (en) | 2009-10-01 | 2011-04-07 | Jonathan Dahlgren | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
US8808369B2 (en) * | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US8734467B2 (en) | 2009-12-02 | 2014-05-27 | Valtech Cardio, Ltd. | Delivery tool for implantation of spool assembly coupled to a helical anchor |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
US8475525B2 (en) | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US9307980B2 (en) | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US9107749B2 (en) | 2010-02-03 | 2015-08-18 | Edwards Lifesciences Corporation | Methods for treating a heart |
US9226826B2 (en) * | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
WO2011109813A2 (en) | 2010-03-05 | 2011-09-09 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
CN103002833B (en) | 2010-05-25 | 2016-05-11 | 耶拿阀门科技公司 | Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese |
US9050066B2 (en) | 2010-06-07 | 2015-06-09 | Kardium Inc. | Closing openings in anatomical tissue |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9132009B2 (en) | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
US8992604B2 (en) | 2010-07-21 | 2015-03-31 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
CN103118629A (en) | 2010-09-01 | 2013-05-22 | 美敦力瓦斯科尔勒戈尔韦有限公司 | Prosthetic valve support structure |
AU2011295854B2 (en) * | 2010-09-01 | 2016-07-21 | Mvalve Technologies Ltd. | Cardiac valve support structure |
US10105224B2 (en) | 2010-09-01 | 2018-10-23 | Mvalve Technologies Ltd. | Cardiac valve support structure |
CN106073946B (en) | 2010-09-10 | 2022-01-04 | 西美蒂斯股份公司 | Valve replacement device, delivery device for a valve replacement device and method of producing a valve replacement device |
US8940002B2 (en) | 2010-09-30 | 2015-01-27 | Kardium Inc. | Tissue anchor system |
EP2478868A1 (en) | 2011-01-25 | 2012-07-25 | The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth | Implant device |
US8845717B2 (en) | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
US8888843B2 (en) | 2011-01-28 | 2014-11-18 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valve regurgitation |
EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
EP2486893B1 (en) | 2011-02-14 | 2017-07-05 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
US9011523B2 (en) | 2011-06-20 | 2015-04-21 | Jacques Seguin | Prosthetic leaflet assembly for repairing a defective cardiac valve and methods of using the same |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
WO2013009975A1 (en) | 2011-07-12 | 2013-01-17 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
EP3417813B1 (en) | 2011-08-05 | 2020-05-13 | Cardiovalve Ltd | Percutaneous mitral valve replacement |
US9549817B2 (en) * | 2011-09-22 | 2017-01-24 | Transmural Systems Llc | Devices, systems and methods for repairing lumenal systems |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
US9724192B2 (en) | 2011-11-08 | 2017-08-08 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
WO2013076724A2 (en) | 2011-11-21 | 2013-05-30 | Mor Research Applications Ltd. | Device for placement in the tricuspid annulus |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
EP2609893B1 (en) | 2011-12-29 | 2014-09-03 | Sorin Group Italia S.r.l. | A kit for implanting prosthetic vascular conduits |
US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
WO2013114214A2 (en) | 2012-01-31 | 2013-08-08 | Orford Holdings Sa | Mitral valve docking devices, systems and methods |
WO2013120082A1 (en) | 2012-02-10 | 2013-08-15 | Kassab Ghassan S | Methods and uses of biological tissues for various stent and other medical applications |
WO2013128432A1 (en) | 2012-02-28 | 2013-09-06 | Mvalve Technologies Ltd. | Cardiac valve support structure |
US20130304197A1 (en) * | 2012-02-28 | 2013-11-14 | Mvalve Technologies Ltd. | Cardiac valve modification device |
WO2013128436A1 (en) * | 2012-02-28 | 2013-09-06 | Mvalve Technologies Ltd. | Single-ring cardiac valve support |
ES2675936T3 (en) | 2012-03-23 | 2018-07-13 | Sorin Group Italia S.R.L. | Folding valve prosthesis |
US9011515B2 (en) | 2012-04-19 | 2015-04-21 | Caisson Interventional, LLC | Heart valve assembly systems and methods |
US9427315B2 (en) * | 2012-04-19 | 2016-08-30 | Caisson Interventional, LLC | Valve replacement systems and methods |
DE102012010798A1 (en) * | 2012-06-01 | 2013-12-05 | Universität Duisburg-Essen | Implantable device for improving or eliminating heart valve insufficiency |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
EP2695586B1 (en) | 2012-08-10 | 2019-05-08 | Sorin Group Italia S.r.l. | A valve prosthesis and kit |
WO2014052818A1 (en) | 2012-09-29 | 2014-04-03 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
EP3730084A1 (en) | 2012-10-23 | 2020-10-28 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US10376266B2 (en) | 2012-10-23 | 2019-08-13 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US8628571B1 (en) | 2012-11-13 | 2014-01-14 | Mitraltech Ltd. | Percutaneously-deliverable mechanical valve |
US9730793B2 (en) | 2012-12-06 | 2017-08-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
WO2014108903A1 (en) | 2013-01-09 | 2014-07-17 | 4Tech Inc. | Soft tissue anchors |
US20200030096A1 (en) * | 2013-01-10 | 2020-01-30 | Innercore Medical Ltd. | Devices and implantation methods for treating mitral valve condition |
US20140200662A1 (en) * | 2013-01-16 | 2014-07-17 | Mvalve Technologies Ltd. | Anchoring elements for intracardiac devices |
US20150351906A1 (en) | 2013-01-24 | 2015-12-10 | Mitraltech Ltd. | Ventricularly-anchored prosthetic valves |
EP2953580A2 (en) | 2013-02-11 | 2015-12-16 | Cook Medical Technologies LLC | Expandable support frame and medical device |
US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
EP2967931B8 (en) | 2013-03-14 | 2017-04-12 | 4Tech Inc. | Stent with tether interface |
CN105283214B (en) | 2013-03-15 | 2018-10-16 | 北京泰德制药股份有限公司 | Translate conduit, system and its application method |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
JP6561044B2 (en) | 2013-05-03 | 2019-08-14 | メドトロニック,インコーポレイテッド | Valve transfer tool |
WO2014181336A1 (en) | 2013-05-09 | 2014-11-13 | Mitrassist Medical Ltd. | Heart valve assistive prosthesis |
US10111747B2 (en) | 2013-05-20 | 2018-10-30 | Twelve, Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
WO2014207575A2 (en) * | 2013-06-14 | 2014-12-31 | Hazu Gmbh | Method and device for treatment of valve regurgitation |
US9895219B2 (en) * | 2013-07-31 | 2018-02-20 | Medtronic Vascular Galway | Mitral valve prosthesis for transcatheter valve implantation |
EP2835112B1 (en) | 2013-08-08 | 2021-01-27 | Sorin Group Italia S.r.l. | Heart valve prosthesis |
CN107744416B (en) * | 2013-08-12 | 2021-08-31 | 米特拉尔维尔福科技有限责任公司 | Apparatus and method for implanting a replacement heart valve |
CA2920865C (en) | 2013-08-14 | 2023-06-06 | Mitral Valve Technologies Sarl | Replacement heart valve apparatus and methods |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
US9050188B2 (en) | 2013-10-23 | 2015-06-09 | Caisson Interventional, LLC | Methods and systems for heart valve therapy |
US10646333B2 (en) | 2013-10-24 | 2020-05-12 | Medtronic, Inc. | Two-piece valve prosthesis with anchor stent and valve component |
US10166098B2 (en) | 2013-10-25 | 2019-01-01 | Middle Peak Medical, Inc. | Systems and methods for transcatheter treatment of valve regurgitation |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
WO2015079443A1 (en) * | 2013-11-28 | 2015-06-04 | Mvalve Technologies Ltd. | Intracardiac devices comprising stabilizing elements having improved fatigue resistance |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
WO2015127264A1 (en) | 2014-02-20 | 2015-08-27 | Mitral Valve Technologies Sarl | Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device |
EP3107498B1 (en) | 2014-02-21 | 2020-09-30 | Mitral Valve Technologies Sàrl | Prosthetic mitral valve with anchoring device |
US10245141B2 (en) | 2014-05-14 | 2019-04-02 | Sorin Group Italia S.R.L. | Implant device and implantation kit |
US9974647B2 (en) | 2014-06-12 | 2018-05-22 | Caisson Interventional, LLC | Two stage anchor and mitral valve assembly |
CA2958061A1 (en) | 2014-06-18 | 2015-12-23 | Middle Peak Medical, Inc. | Mitral valve implants for the treatment of valvular regurgitation |
CN106573129B (en) | 2014-06-19 | 2019-09-24 | 4科技有限公司 | Heart tissue is tightened |
CN107072784B (en) | 2014-06-24 | 2019-07-05 | 中峰医疗公司 | System and method for anchoring implantation material |
EP4066786A1 (en) | 2014-07-30 | 2022-10-05 | Cardiovalve Ltd. | Articulatable prosthetic valve |
US10016272B2 (en) | 2014-09-12 | 2018-07-10 | Mitral Valve Technologies Sarl | Mitral repair and replacement devices and methods |
WO2016059639A1 (en) | 2014-10-14 | 2016-04-21 | Valtech Cardio Ltd. | Leaflet-restraining techniques |
FR3027212A1 (en) | 2014-10-16 | 2016-04-22 | Seguin Jacques | INTERVALVULAR IMPLANT FOR MITRAL VALVE |
US9750605B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
US9750607B2 (en) | 2014-10-23 | 2017-09-05 | Caisson Interventional, LLC | Systems and methods for heart valve therapy |
CN107106296A (en) | 2014-11-17 | 2017-08-29 | 二尖瓣辅助治疗有限公司 | For valvular servicing unit |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
EP3284412A1 (en) | 2014-12-02 | 2018-02-21 | 4Tech Inc. | Off-center tissue anchors |
CN111437068B (en) | 2014-12-04 | 2023-01-17 | 爱德华兹生命科学公司 | Percutaneous clamp for repairing heart valve |
BR112017012669B1 (en) | 2014-12-14 | 2023-03-28 | Trisol Medical Ltd | PROSTHETIC VALVE |
US10449043B2 (en) | 2015-01-16 | 2019-10-22 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US10201417B2 (en) | 2015-02-03 | 2019-02-12 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
WO2016125160A1 (en) | 2015-02-05 | 2016-08-11 | Mitraltech Ltd. | Prosthetic valve with axially-sliding frames |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
US10039637B2 (en) | 2015-02-11 | 2018-08-07 | Edwards Lifesciences Corporation | Heart valve docking devices and implanting methods |
US20160235525A1 (en) | 2015-02-12 | 2016-08-18 | Medtronic, Inc. | Integrated valve assembly and method of delivering and deploying an integrated valve assembly |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
EP3270827B1 (en) | 2015-03-19 | 2023-12-20 | Caisson Interventional, LLC | Systems for heart valve therapy |
SG10202010021SA (en) | 2015-04-30 | 2020-11-27 | Valtech Cardio Ltd | Annuloplasty technologies |
JP6767388B2 (en) | 2015-05-01 | 2020-10-14 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Devices and methods to reduce the proportion of pacemakers in heart valve replacement |
US9629720B2 (en) * | 2015-05-04 | 2017-04-25 | Jacques Seguin | Apparatus and methods for treating cardiac valve regurgitation |
WO2016183485A1 (en) | 2015-05-14 | 2016-11-17 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10335277B2 (en) | 2015-07-02 | 2019-07-02 | Boston Scientific Scimed Inc. | Adjustable nosecone |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10238490B2 (en) | 2015-08-21 | 2019-03-26 | Twelve, Inc. | Implant heart valve devices, mitral valve repair devices and associated systems and methods |
US10034747B2 (en) | 2015-08-27 | 2018-07-31 | Medtronic Vascular, Inc. | Prosthetic valve system having a docking component and a prosthetic valve component |
US20170056215A1 (en) | 2015-09-01 | 2017-03-02 | Medtronic, Inc. | Stent assemblies including passages to provide blood flow to coronary arteries and methods of delivering and deploying such stent assemblies |
WO2017059406A1 (en) | 2015-10-01 | 2017-04-06 | Neochord, Inc. | Ringless web for repair of heart valves |
US9592121B1 (en) | 2015-11-06 | 2017-03-14 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
EP3397208B1 (en) | 2015-12-30 | 2020-12-02 | Caisson Interventional, LLC | Systems for heart valve therapy |
WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
CN108882957B (en) * | 2016-02-10 | 2022-09-16 | 埃米尔·贝尔森 | Personalized atrial fibrillation ablation |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US11219746B2 (en) | 2016-03-21 | 2022-01-11 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
EP4183371A1 (en) | 2016-05-13 | 2023-05-24 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
US20200146854A1 (en) | 2016-05-16 | 2020-05-14 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
US11116635B2 (en) | 2016-06-13 | 2021-09-14 | Singapore Health Services Pte Ltd | Device for cardiac valve repair and method of implanting the same |
US10588745B2 (en) | 2016-06-20 | 2020-03-17 | Medtronic Vascular, Inc. | Modular valve prosthesis, delivery system, and method of delivering and deploying a modular valve prosthesis |
US10973638B2 (en) | 2016-07-07 | 2021-04-13 | Edwards Lifesciences Corporation | Device and method for treating vascular insufficiency |
US10828150B2 (en) * | 2016-07-08 | 2020-11-10 | Edwards Lifesciences Corporation | Docking station for heart valve prosthesis |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
WO2018029680A1 (en) | 2016-08-10 | 2018-02-15 | Mitraltech Ltd. | Prosthetic valve with concentric frames |
US10653862B2 (en) | 2016-11-07 | 2020-05-19 | Edwards Lifesciences Corporation | Apparatus for the introduction and manipulation of multiple telescoping catheters |
AU2017382273A1 (en) | 2016-12-22 | 2019-08-08 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
US10905554B2 (en) | 2017-01-05 | 2021-02-02 | Edwards Lifesciences Corporation | Heart valve coaptation device |
WO2018131042A1 (en) | 2017-01-11 | 2018-07-19 | Mitrassist Medical Ltd. | Heart valve prosthesis |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11419719B2 (en) | 2017-02-06 | 2022-08-23 | Mtex Cardio Ag | Methods and systems for assisting or repairing prosthetic cardiac valves |
CA3056423A1 (en) | 2017-03-13 | 2018-09-20 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US10478303B2 (en) | 2017-03-13 | 2019-11-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US10653524B2 (en) | 2017-03-13 | 2020-05-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
CN110603007A (en) * | 2017-03-27 | 2019-12-20 | 维维泰生物医药有限公司 | Devices and methods for transcatheter mitral and tricuspid valve repair |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US11224511B2 (en) | 2017-04-18 | 2022-01-18 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
ES2906555T3 (en) | 2017-04-18 | 2022-04-19 | Edwards Lifesciences Corp | Heart valve sealing devices and delivery devices therefor |
US10799312B2 (en) | 2017-04-28 | 2020-10-13 | Edwards Lifesciences Corporation | Medical device stabilizing apparatus and method of use |
US10959846B2 (en) | 2017-05-10 | 2021-03-30 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
US10828154B2 (en) | 2017-06-08 | 2020-11-10 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
WO2019028161A1 (en) | 2017-08-01 | 2019-02-07 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US10939996B2 (en) | 2017-08-16 | 2021-03-09 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11173032B2 (en) * | 2017-08-28 | 2021-11-16 | Edwards Lifesciences Corporation | Transcatheter device for treating mitral regurgitation |
US11051940B2 (en) | 2017-09-07 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic spacer device for heart valve |
US11065117B2 (en) | 2017-09-08 | 2021-07-20 | Edwards Lifesciences Corporation | Axisymmetric adjustable device for treating mitral regurgitation |
US11040174B2 (en) | 2017-09-19 | 2021-06-22 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US11304806B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve Ltd. | Prosthetic valve with atrial tissue anchors having variable flexibility and ventricular tissue anchors having constant flexibility |
US9895226B1 (en) | 2017-10-19 | 2018-02-20 | Mitral Tech Ltd. | Techniques for use with prosthetic valve leaflets |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
US10136993B1 (en) | 2018-01-09 | 2018-11-27 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10238493B1 (en) | 2018-01-09 | 2019-03-26 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10231837B1 (en) | 2018-01-09 | 2019-03-19 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10076415B1 (en) | 2018-01-09 | 2018-09-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10245144B1 (en) | 2018-01-09 | 2019-04-02 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10973639B2 (en) | 2018-01-09 | 2021-04-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10111751B1 (en) | 2018-01-09 | 2018-10-30 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
CA3086678A1 (en) | 2018-01-09 | 2019-07-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10159570B1 (en) | 2018-01-09 | 2018-12-25 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10105222B1 (en) | 2018-01-09 | 2018-10-23 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
WO2019144069A2 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Inductance mode deployment sensors for transcatheter valve system |
WO2019144071A1 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
EP3720389A1 (en) | 2018-01-22 | 2020-10-14 | Edwards Lifesciences Corporation | Heart shape preserving anchor |
WO2019145947A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
US11147668B2 (en) | 2018-02-07 | 2021-10-19 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
US11439732B2 (en) | 2018-02-26 | 2022-09-13 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
WO2019195860A2 (en) | 2018-04-04 | 2019-10-10 | Vdyne, Llc | Devices and methods for anchoring transcatheter heart valve |
US11389297B2 (en) | 2018-04-12 | 2022-07-19 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US11207181B2 (en) | 2018-04-18 | 2021-12-28 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11229517B2 (en) | 2018-05-15 | 2022-01-25 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
WO2019224577A1 (en) | 2018-05-23 | 2019-11-28 | Sorin Group Italia S.R.L. | A cardiac valve prosthesis |
WO2019241477A1 (en) | 2018-06-13 | 2019-12-19 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
CA3106104A1 (en) | 2018-07-12 | 2020-01-16 | Valtech Cardio, Ltd. | Annuloplasty systems and locking tools therefor |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
US10779946B2 (en) | 2018-09-17 | 2020-09-22 | Cardiovalve Ltd. | Leaflet-testing apparatus |
US10321995B1 (en) | 2018-09-20 | 2019-06-18 | Vdyne, Llc | Orthogonally delivered transcatheter heart valve replacement |
US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
US10945844B2 (en) | 2018-10-10 | 2021-03-16 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
EP3880124A1 (en) * | 2018-11-14 | 2021-09-22 | Half Moon Medical, Inc. | Leaflet extension for cardiac valve leaflet |
US11241312B2 (en) | 2018-12-10 | 2022-02-08 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
EP3917486B1 (en) | 2019-01-31 | 2023-03-08 | West Pharma. Services IL, Ltd | Liquid transfer device |
CR20210427A (en) | 2019-02-14 | 2022-03-30 | Edwards Lifesciences Corp | Heart valve sealing devices and delivery devices therefor |
CN113543750A (en) * | 2019-03-05 | 2021-10-22 | 维迪内股份有限公司 | Tricuspid valve regurgitation control apparatus for orthogonal transcatheter heart valve prosthesis |
WO2020222220A1 (en) | 2019-04-30 | 2020-11-05 | West Pharma. Services IL, Ltd. | Liquid transfer device with dual lumen iv spike |
CN114072106A (en) | 2019-05-04 | 2022-02-18 | 维迪内股份有限公司 | Cinching device and method for deploying a laterally delivered prosthetic heart valve in a native annulus |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
US11944536B2 (en) * | 2019-08-13 | 2024-04-02 | The Chinese University Of Hong Kong | Transcatheter self-expandable tricuspid valve replacement system |
JP2022544707A (en) | 2019-08-20 | 2022-10-20 | ブイダイン,インコーポレイテッド | Devices and methods for delivery and retrieval of laterally deliverable transcatheter valve prostheses |
WO2021040996A1 (en) | 2019-08-26 | 2021-03-04 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
WO2021084407A1 (en) | 2019-10-29 | 2021-05-06 | Valtech Cardio, Ltd. | Annuloplasty and tissue anchor technologies |
US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
WO2021158509A1 (en) * | 2020-02-06 | 2021-08-12 | Laplace Interventional Inc. | Transcatheter heart valve prosthesis assembled inside heart chambers or blood vessels |
USD956958S1 (en) | 2020-07-13 | 2022-07-05 | West Pharma. Services IL, Ltd. | Liquid transfer device |
US11464634B2 (en) | 2020-12-16 | 2022-10-11 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors |
US11759321B2 (en) | 2021-06-25 | 2023-09-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
Family Cites Families (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4056854A (en) * | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
US4275469A (en) * | 1979-12-13 | 1981-06-30 | Shelhigh Inc. | Prosthetic heart valve |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US4994077A (en) * | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
US5609626A (en) * | 1989-05-31 | 1997-03-11 | Baxter International Inc. | Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts |
DK124690D0 (en) * | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
JPH05184611A (en) | 1991-03-19 | 1993-07-27 | Kenji Kusuhara | Valvular annulation retaining member and its attaching method |
IT1247037B (en) * | 1991-06-25 | 1994-12-12 | Sante Camilli | ARTIFICIAL VENOUS VALVE |
US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US5792155A (en) * | 1991-07-16 | 1998-08-11 | Van Cleef; Jean-Francois | Process for partially or totally flattening a vein |
DE69330003T2 (en) * | 1993-12-14 | 2001-10-04 | Sante Camilli | Percutaneously implantable valve for blood vessels |
US5545241B1 (en) * | 1995-01-17 | 1999-09-28 | Donaldson Co Inc | Air cleaner |
US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
EP0808614B1 (en) * | 1996-05-23 | 2003-02-26 | Samsung Electronics Co., Ltd. | Flexible self-expandable stent and method for making the same |
US5855601A (en) * | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US5716397A (en) * | 1996-12-06 | 1998-02-10 | Medtronic, Inc. | Annuloplasty device with removable stiffening element |
NL1004827C2 (en) * | 1996-12-18 | 1998-06-19 | Surgical Innovations Vof | Device for regulating blood circulation. |
EP0850607A1 (en) * | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
US5961440A (en) * | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6183411B1 (en) * | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6050936A (en) * | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6045497A (en) | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US5776189A (en) * | 1997-03-05 | 1998-07-07 | Khalid; Naqeeb | Cardiac valvular support prosthesis |
US5957949A (en) * | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6245102B1 (en) * | 1997-05-07 | 2001-06-12 | Iowa-India Investments Company Ltd. | Stent, stent graft and stent valve |
US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6530952B2 (en) * | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
AU2011699A (en) * | 1997-12-29 | 1999-07-19 | Ivan Vesely | System for minimally invasive insertion of a bioprosthetic heart valve |
US7452371B2 (en) * | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
JP4399585B2 (en) * | 1998-06-02 | 2010-01-20 | クック インコーポレイティド | Multi-sided medical device |
US6260552B1 (en) * | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6254564B1 (en) * | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6102932A (en) * | 1998-12-15 | 2000-08-15 | Micrus Corporation | Intravascular device push wire delivery system |
JP4230118B2 (en) * | 1999-01-26 | 2009-02-25 | エドワーズ ライフサイエンシーズ コーポレイション | Flexible heart valve |
US6425916B1 (en) * | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
ATE484241T1 (en) * | 1999-04-09 | 2010-10-15 | Evalve Inc | METHOD AND DEVICE FOR HEART VALVE REPAIR |
EP1171059B1 (en) * | 1999-04-23 | 2005-11-02 | St. Jude Medical ATG, Inc. | Artificial heart valve attachment apparatus |
US6312464B1 (en) * | 1999-04-28 | 2001-11-06 | NAVIA JOSé L. | Method of implanting a stentless cardiac valve prosthesis |
US6478819B2 (en) * | 1999-05-27 | 2002-11-12 | Sulzer Carbomedics Inc. | Prosthetic heart valves with flexible post geometry |
US6287339B1 (en) * | 1999-05-27 | 2001-09-11 | Sulzer Carbomedics Inc. | Sutureless heart valve prosthesis |
US7628803B2 (en) * | 2001-02-05 | 2009-12-08 | Cook Incorporated | Implantable vascular device |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
SE514718C2 (en) * | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
US6312465B1 (en) * | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
US6299637B1 (en) * | 1999-08-20 | 2001-10-09 | Samuel M. Shaolian | Transluminally implantable venous valve |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US7195641B2 (en) * | 1999-11-19 | 2007-03-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Valvular prostheses having metal or pseudometallic construction and methods of manufacture |
US6458153B1 (en) * | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
US6821297B2 (en) * | 2000-02-02 | 2004-11-23 | Robert V. Snyders | Artificial heart valve, implantation instrument and method therefor |
US6797002B2 (en) * | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
US6537198B1 (en) * | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US6454799B1 (en) * | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
US6652583B2 (en) * | 2000-04-07 | 2003-11-25 | Rhode Island Hospital | Cardiac valve replacement |
US6419695B1 (en) * | 2000-05-22 | 2002-07-16 | Shlomo Gabbay | Cardiac prosthesis for helping improve operation of a heart valve |
EP1330189B1 (en) * | 2000-06-23 | 2007-12-19 | Viacor Incorporated | Automated annular plication for mitral valve repair |
US6676698B2 (en) * | 2000-06-26 | 2004-01-13 | Rex Medicol, L.P. | Vascular device with valve for approximating vessel wall |
US6419696B1 (en) * | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US6773454B2 (en) * | 2000-08-02 | 2004-08-10 | Michael H. Wholey | Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms |
US7510572B2 (en) * | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
WO2004030570A2 (en) * | 2002-10-01 | 2004-04-15 | Ample Medical, Inc. | Devices for retaining native heart valve leaflet |
US8956407B2 (en) * | 2000-09-20 | 2015-02-17 | Mvrx, Inc. | Methods for reshaping a heart valve annulus using a tensioning implant |
US6893459B1 (en) * | 2000-09-20 | 2005-05-17 | Ample Medical, Inc. | Heart valve annulus device and method of using same |
WO2004030568A2 (en) * | 2002-10-01 | 2004-04-15 | Ample Medical, Inc. | Device and method for repairing a native heart valve leaflet |
US6616684B1 (en) | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6913608B2 (en) * | 2000-10-23 | 2005-07-05 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US7070618B2 (en) * | 2000-10-25 | 2006-07-04 | Viacor, Inc. | Mitral shield |
US6602286B1 (en) * | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US6482228B1 (en) * | 2000-11-14 | 2002-11-19 | Troy R. Norred | Percutaneous aortic valve replacement |
US6494909B2 (en) * | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
US6696074B2 (en) * | 2000-12-04 | 2004-02-24 | Tei Biosciences, Inc. | Processing fetal or neo-natal tissue to produce a scaffold for tissue engineering |
US6656221B2 (en) | 2001-02-05 | 2003-12-02 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US8038708B2 (en) * | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
US6955689B2 (en) * | 2001-03-15 | 2005-10-18 | Medtronic, Inc. | Annuloplasty band and method |
US6503272B2 (en) * | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US6733525B2 (en) * | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
KR100393548B1 (en) * | 2001-06-05 | 2003-08-02 | 주식회사 엠아이텍 | Stent |
US7377938B2 (en) * | 2001-07-19 | 2008-05-27 | The Cleveland Clinic Foundation | Prosthetic cardiac value and method for making same |
FR2828091B1 (en) * | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
AU2002362442B2 (en) * | 2001-10-01 | 2008-08-07 | Ample Medical, Inc. | Methods and devices for heart valve treatments |
US20040243107A1 (en) * | 2001-10-01 | 2004-12-02 | Macoviak John A | Methods and devices for treating atrial fibrilation |
US6790237B2 (en) * | 2001-10-09 | 2004-09-14 | Scimed Life Systems, Inc. | Medical stent with a valve and related methods of manufacturing |
US7128754B2 (en) * | 2001-11-28 | 2006-10-31 | Aptus Endosystems, Inc. | Catheter-based fastener implantation apparatus and methods |
US20030120340A1 (en) | 2001-12-26 | 2003-06-26 | Jan Liska | Mitral and tricuspid valve repair |
US6764510B2 (en) * | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6716241B2 (en) * | 2002-03-05 | 2004-04-06 | John G. Wilder | Venous valve and graft combination |
US7163556B2 (en) * | 2002-03-21 | 2007-01-16 | Providence Health System - Oregon | Bioprosthesis and method for suturelessly making same |
US6752828B2 (en) * | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
US7160320B2 (en) * | 2002-04-16 | 2007-01-09 | The International Heart Institute Of Montana Foundation | Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support |
US7125418B2 (en) * | 2002-04-16 | 2006-10-24 | The International Heart Institute Of Montana Foundation | Sigmoid valve and method for its percutaneous implantation |
US6676699B2 (en) * | 2002-04-26 | 2004-01-13 | Medtronic Ave, Inc | Stent graft with integrated valve device and method |
US7351256B2 (en) * | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US7112219B2 (en) * | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6945978B1 (en) * | 2002-11-15 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Heart valve catheter |
US7399315B2 (en) * | 2003-03-18 | 2008-07-15 | Edwards Lifescience Corporation | Minimally-invasive heart valve with cusp positioners |
WO2004089253A1 (en) * | 2003-04-01 | 2004-10-21 | Cook Incorporated | Percutaneously deployed vascular valves |
US7159593B2 (en) * | 2003-04-17 | 2007-01-09 | 3F Therapeutics, Inc. | Methods for reduction of pressure effects of cardiac tricuspid valve regurgitation |
US8221492B2 (en) * | 2003-04-24 | 2012-07-17 | Cook Medical Technologies | Artificial valve prosthesis with improved flow dynamics |
US7717952B2 (en) * | 2003-04-24 | 2010-05-18 | Cook Incorporated | Artificial prostheses with preferred geometries |
DE602004021799D1 (en) * | 2003-05-19 | 2009-08-13 | Cook Inc | IMPLANTABLE MEDICAL DEVICE WITH LIMITED EXPANSION |
US7201772B2 (en) * | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
CA2533353A1 (en) * | 2003-07-21 | 2005-02-03 | The Trustees Of The University Of Pennsylvania | Percutaneous heart valve |
WO2005011535A2 (en) * | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve for implantation in a body vessel |
EP1659992B1 (en) * | 2003-07-31 | 2013-03-27 | Cook Medical Technologies LLC | Prosthetic valve devices and methods of making such devices |
US7004176B2 (en) * | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US7347869B2 (en) * | 2003-10-31 | 2008-03-25 | Cordis Corporation | Implantable valvular prosthesis |
US8128681B2 (en) * | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7329279B2 (en) * | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7748389B2 (en) * | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7445631B2 (en) * | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8182528B2 (en) * | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US7381219B2 (en) * | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US8828078B2 (en) * | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
EP2529699B1 (en) * | 2003-12-23 | 2014-01-29 | Sadra Medical, Inc. | Repositionable heart valve |
US8951299B2 (en) * | 2003-12-23 | 2015-02-10 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US8343213B2 (en) * | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8287584B2 (en) * | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US7311730B2 (en) * | 2004-02-13 | 2007-12-25 | Shlomo Gabbay | Support apparatus and heart valve prosthesis for sutureless implantation |
WO2005082289A1 (en) * | 2004-02-20 | 2005-09-09 | Cook Incorporated | Prosthetic valve with spacing member |
ITTO20040135A1 (en) * | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
US20050228468A1 (en) * | 2004-04-01 | 2005-10-13 | Macoviak John A | Devices, systems, and methods for treating atrial fibrillation |
US7361168B2 (en) * | 2004-04-21 | 2008-04-22 | Acclarent, Inc. | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders |
US7566343B2 (en) * | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US6951571B1 (en) * | 2004-09-30 | 2005-10-04 | Rohit Srivastava | Valve implanting device |
US20090043381A1 (en) * | 2004-10-05 | 2009-02-12 | Macoviak John A | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
US7458987B2 (en) * | 2004-10-29 | 2008-12-02 | Cook Incorporated | Vascular valves having implanted and target configurations and methods of preparing the same |
US7670368B2 (en) * | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7867274B2 (en) * | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7722666B2 (en) * | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
US8012198B2 (en) * | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
WO2007025028A1 (en) * | 2005-08-25 | 2007-03-01 | The Cleveland Clinic Foundation | Percutaneous atrioventricular valve and method of use |
US7569071B2 (en) * | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7503928B2 (en) * | 2005-10-21 | 2009-03-17 | Cook Biotech Incorporated | Artificial valve with center leaflet attachment |
AU2006315812B2 (en) * | 2005-11-10 | 2013-03-28 | Cardiaq Valve Technologies, Inc. | Balloon-expandable, self-expanding, vascular prosthesis connecting stent |
EP2583640B1 (en) * | 2006-02-16 | 2022-06-22 | Venus MedTech (HangZhou), Inc. | Minimally invasive replacement heart valve |
US7648527B2 (en) * | 2006-03-01 | 2010-01-19 | Cook Incorporated | Methods of reducing retrograde flow |
US7524331B2 (en) * | 2006-04-06 | 2009-04-28 | Medtronic Vascular, Inc. | Catheter delivered valve having a barrier to provide an enhanced seal |
US8454684B2 (en) * | 2006-08-02 | 2013-06-04 | Medtronic, Inc. | Heart valve holder for use in valve implantation procedures |
US10624621B2 (en) * | 2006-11-07 | 2020-04-21 | Corvia Medical, Inc. | Devices and methods for the treatment of heart failure |
WO2008091493A1 (en) * | 2007-01-08 | 2008-07-31 | California Institute Of Technology | In-situ formation of a valve |
US7678144B2 (en) * | 2007-01-29 | 2010-03-16 | Cook Incorporated | Prosthetic valve with slanted leaflet design |
WO2008097589A1 (en) * | 2007-02-05 | 2008-08-14 | Boston Scientific Limited | Percutaneous valve, system, and method |
US8070802B2 (en) * | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US20080208328A1 (en) * | 2007-02-23 | 2008-08-28 | Endovalve, Inc. | Systems and Methods For Placement of Valve Prosthesis System |
US7896915B2 (en) * | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8403979B2 (en) * | 2007-05-17 | 2013-03-26 | Cook Medical Technologies Llc | Monocuspid prosthetic valve having a partial sinus |
US7806921B2 (en) * | 2007-11-08 | 2010-10-05 | Cook Incorporated | Monocusp valve design |
US7846199B2 (en) * | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
US8216303B2 (en) * | 2007-11-19 | 2012-07-10 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US8057532B2 (en) * | 2007-11-28 | 2011-11-15 | Cook Medical Technologies Llc | Implantable frame and valve design |
US7892276B2 (en) * | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US8100962B2 (en) * | 2008-01-08 | 2012-01-24 | Cook Medical Technologies Llc | Flow-deflecting prosthesis for treating venous disease |
WO2009094373A1 (en) * | 2008-01-22 | 2009-07-30 | Cook Incorporated | Valve frame |
US8317858B2 (en) * | 2008-02-26 | 2012-11-27 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US7806919B2 (en) * | 2008-04-01 | 2010-10-05 | Medtronic Vascular, Inc. | Double-walled stent system |
EP2334261B1 (en) * | 2008-07-21 | 2021-01-13 | Jenesis Surgical, LLC | Endoluminal support apparatus and method of fabricating it |
US8308798B2 (en) * | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
US8075611B2 (en) * | 2009-06-02 | 2011-12-13 | Medtronic, Inc. | Stented prosthetic heart valves |
DE102010008360A1 (en) * | 2010-02-17 | 2011-09-29 | Transcatheter Technologies Gmbh | Medical implant in which gaps remain during crimping or folding, method and device for moving |
WO2011115799A2 (en) * | 2010-03-17 | 2011-09-22 | Deep Vein Medical, Inc. | Fatigue-resistant flow regulating device and manufacturing methods |
EP2754414A4 (en) * | 2011-09-09 | 2015-09-02 | Shinkan Kogyo K K | Stent with valve, base material for forming stent with valve, and method for producing stent with valve |
-
2003
- 2003-10-01 WO PCT/US2003/030830 patent/WO2004030568A2/en not_active Application Discontinuation
- 2003-10-01 AU AU2003277115A patent/AU2003277115A1/en not_active Abandoned
- 2003-10-01 US US10/676,815 patent/US7381220B2/en not_active Expired - Lifetime
-
2007
- 2007-10-31 US US11/981,025 patent/US8016882B2/en not_active Expired - Fee Related
-
2011
- 2011-09-08 US US13/227,630 patent/US9610161B2/en not_active Expired - Lifetime
-
2012
- 2012-03-27 US US13/431,430 patent/US20120185040A1/en not_active Abandoned
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9610161B2 (en) * | 2000-09-20 | 2017-04-04 | Mvrx, Inc. | Devices, systems, and methods for supplementing, repairing or replacing a native heart valve leaflet |
US11357549B2 (en) | 2004-07-02 | 2022-06-14 | Nuvasive Specialized Orthopedics, Inc. | Expandable rod system to treat scoliosis and method of using the same |
US11234849B2 (en) | 2006-10-20 | 2022-02-01 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US11672684B2 (en) | 2006-10-20 | 2023-06-13 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US20120179247A1 (en) * | 2007-11-19 | 2012-07-12 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US8784483B2 (en) * | 2007-11-19 | 2014-07-22 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US11202707B2 (en) | 2008-03-25 | 2021-12-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant system |
US20110202129A1 (en) * | 2008-10-10 | 2011-08-18 | Milux Holding S.A. | Improved artificial valve |
US9452045B2 (en) * | 2008-10-10 | 2016-09-27 | Peter Forsell | Artificial valve |
US10729470B2 (en) | 2008-11-10 | 2020-08-04 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10478232B2 (en) | 2009-04-29 | 2019-11-19 | Nuvasive Specialized Orthopedics, Inc. | Interspinous process device and method |
US10660675B2 (en) | 2010-06-30 | 2020-05-26 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10646262B2 (en) | 2011-02-14 | 2020-05-12 | Nuvasive Specialized Orthopedics, Inc. | System and method for altering rotational alignment of bone sections |
US10743794B2 (en) | 2011-10-04 | 2020-08-18 | Nuvasive Specialized Orthopedics, Inc. | Devices and methods for non-invasive implant length sensing |
US10349982B2 (en) | 2011-11-01 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US11123107B2 (en) | 2011-11-01 | 2021-09-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US9224542B2 (en) | 2012-07-26 | 2015-12-29 | Samsung Electronics Co., Ltd. | Conductive layered structure, electrode and supercapacitor comprising the conductive layered structure, and method for preparing the conductive layered structure |
US11191579B2 (en) | 2012-10-29 | 2021-12-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US11213330B2 (en) | 2012-10-29 | 2022-01-04 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US10751094B2 (en) | 2013-10-10 | 2020-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable spinal implant |
US11246694B2 (en) | 2014-04-28 | 2022-02-15 | Nuvasive Specialized Orthopedics, Inc. | System for informational magnetic feedback in adjustable implants |
US11439449B2 (en) | 2014-12-26 | 2022-09-13 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US11612416B2 (en) | 2015-02-19 | 2023-03-28 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US10806576B2 (en) | 2015-10-06 | 2020-10-20 | W. L. Gore & Associates, Inc. | Leaflet support devices and methods of making and using the same |
US10022223B2 (en) | 2015-10-06 | 2018-07-17 | W. L. Gore & Associates, Inc. | Leaflet support devices and methods of making and using the same |
US10617453B2 (en) | 2015-10-16 | 2020-04-14 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US10835290B2 (en) | 2015-12-10 | 2020-11-17 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10918425B2 (en) | 2016-01-28 | 2021-02-16 | Nuvasive Specialized Orthopedics, Inc. | System and methods for bone transport |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11701228B2 (en) | 2018-03-20 | 2023-07-18 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11931261B2 (en) | 2018-03-20 | 2024-03-19 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11951008B2 (en) | 2020-09-30 | 2024-04-09 | Edwards Lifesciences Corporation | Leaflet support devices and methods of making and using the same |
Also Published As
Publication number | Publication date |
---|---|
WO2004030568A3 (en) | 2004-09-30 |
US20110319990A1 (en) | 2011-12-29 |
US20050267573A9 (en) | 2005-12-01 |
WO2004030568A2 (en) | 2004-04-15 |
US8016882B2 (en) | 2011-09-13 |
US7381220B2 (en) | 2008-06-03 |
AU2003277115A8 (en) | 2004-04-23 |
US20050010287A1 (en) | 2005-01-13 |
US9610161B2 (en) | 2017-04-04 |
US20080065204A1 (en) | 2008-03-13 |
AU2003277115A1 (en) | 2004-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8142494B2 (en) | Devices, systems, and methods for retaining a native heart valve leaflet | |
US20120185040A1 (en) | Devices, systems, and methods for retaining a native heart valve leaflet | |
EP1748745B1 (en) | Devices, systems, and methods for reshaping a heart valve annulus | |
US9861475B2 (en) | Devices, systems, and methods for reshaping a heart valve annulus | |
KR102393787B1 (en) | Heart valve restoration device and method of implanting same | |
US8956407B2 (en) | Methods for reshaping a heart valve annulus using a tensioning implant | |
CN111885982A (en) | Flexible canopy valve repair system and method of use | |
US7291168B2 (en) | Methods and devices for heart valve treatments | |
US20140135910A1 (en) | Device and method for reshaping tricuspid valve annulus | |
WO2005055811A2 (en) | Methods and apparatus for mitral valve repair |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MVRX, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:027938/0458 Effective date: 20091130 Owner name: AMPLE MEDICAL, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RAHDERT, DAVID A;MACOVIAK, JOHN A;MACHOLD, TIMOTHY R;AND OTHERS;REEL/FRAME:027938/0371 Effective date: 20031106 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:037705/0289 Effective date: 20041217 Owner name: VENTURE LENDING & LEASING V, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:037705/0660 Effective date: 20080328 Owner name: VENTURE LENDING & LEASING V, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:037706/0025 Effective date: 20091130 Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:037705/0660 Effective date: 20080328 Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMPLE MEDICAL, INC.;REEL/FRAME:037706/0025 Effective date: 20091130 |
|
AS | Assignment |
Owner name: MVRX, INC., CALIFORNIA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE CONVEYING PARTIES PREVIOUSLY RECORDED AT REEL: 027938 FRAME: 0458. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNORS:VENTURE LENDING & LEASING IV, INC.;VENTURE LENDING & LEASING V, INC.;REEL/FRAME:038262/0901 Effective date: 20091130 |